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Summary
The thesis describes a number of examples of the use of recently developed mass
spectrometry experimental approaches to characterise biologically important
mixtures. The recently introduced field of ambient ionisation mass spectrometry has
been utilised in the rapid, sensitive, information rich characterisation of
pharmaceutical formulations. Little, or no, sample treatment was required and the
experiments were shown to provide detailed information on active ingredients in the
presence of a number of other components. A number of ambient ionisation
approaches including DART, DESI and DAPCI were compared and advantages and
disadvantages of each approach outlined and discussed.
The exciting technology of ion mobility has recently been commercially interfaced
with mass spectrometry (IMMS). This has been utilised in a series of fundamental
experiments that probe the interaction of varied cations with isomeric oligomers of
carbohydrates. The approach enables conformational changes to be rapidly measured
over a wide (500-6000 Da) mass range. Changes in conformations were observed for
multiply cationised species which agree with previously measured solution phase
measurements.
The IMMS approach has also been used successfully to characterise a number of N-
linked glycans released from glycoproteins. The experiments enable isomeric
structures to be differentiated and present an opportunity to develop a rapid, high
information content screen. Estimated cross sectional measurements have been
calculated and found to be in good agreement with those obtained from conventional
drift cell approaches.
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Analytical biochemistry
There is a persistent requirement to develop new methods and improved
instrumentation for use in the study of molecules in biological systems. An ideal
analytical technique is sensitive, selective, rapid, reproducible and provides a high
level of information about a sample. Current techniques have a trade-off between one
or more of these properties.
This thesis examines emerging techniques and technologies and assesses their
amenability to improving the throughput in analysis of molecules of biological
importance. The following introduction will focus on the instrumentation and
techniques in the research described here.
Genomics is the study of the genetic complement of a cell or organism. Since the
completion of the first genome sequences there has been a great drive to predict and
annotate all of the potential genes and protein coding regions they contain. The
genetic material contained in most cells is static, and while providing a complete
blueprint for an organism, it does not allow the prediction of the temporal or spatial
expression of its gene products.
Proteomics is the study of the protein complement of a cell, tissue or organism.
Where DNA is predominantly an information storage molecule, proteins are the
driving force behind almost all biochemical reactions. The most important property a
polypeptide chain requires before it is a functional protein is the correct three-
dimensional structure. The correct 3D structure is required for all proteins to function
but there are many proteins that need an additional stage of post-translational
modification to become active. There are more than 400 different post-translational
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modifications (PTMs) that have been observed including: phosphorylation,
glycosylation and disulphide bonds.
Whi
seco
geno
high
biolo
throu
very
DN
non
cha
andFigure 1.1: The central dogma of molecular biology
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er order structure or the presence post-translational modifications in the
gically active molecule. With a greater number of proteins being characterised
gh the use of modern techniques, it is becoming more apparent that PTMs have
important roles and require detailed investigation.
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Glycosylation
Glycosylation is the covalent attachment of carbohydrate structures to the side chains
of amino acids in a polypeptide chain. It one of the most common forms of PTM
present in eukaryotic systems with more than 50% of all proteins having some form
of glycosylation (Apweiler et al., 1999). A wide range of roles have been ascribed to
the presence of glycans. These include presentation (or masking) of molecular
determinants for recognition by cells, microorganisms, or other biological molecules;
modulation of the half-life of glycoproteins; and physical/structural roles (Varki,
1993; Haltiwanger and Lowe, 2004; Ohtsubo and Marth, 2006; Sharon, 2006).
Glycans in cancer
Glycans presented on the surface of a cell are known to have roles in host cell-cell
interaction and recognition. Cell malignancy has been observed to result in
presentation of a different profile of glycans on the surface of the cell (Kim and
Varki, 1997). Detection of the changes in glycosylation profile as a means of cancer
diagnosis is widely practiced. Current approaches use antibodies to glycan structures
known to be presented in certain cancers (Waldmann, 1991). The drawbacks of this
approach are the requirement of an antibody specific to the glycan marker, and
potential binding of the antibody to closely related glycan structures that have no role
in malignancy or tumerogenesis. Thus, more specific detection methods are required.
Glycosylation in pharmaceuticals
The presence of glycosylation in pharmaceuticals ranges from minor carbohydrate
moieties attached to small-molecule drugs (e.g. streptomycin, erythromycin and
oseltamivir (TamifluTM)), to large glycoproteins (e.g. erythropoietin, antibodies and
glycosidases). Glycopeptide and protein pharmaceuticals are a significant challenge
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to produce by in vitro chemical synthesis approaches, and so are produced in
recombinant bacterial or eukaryotic cell lines. These biopharmaceuticals can be used
as treatments for a wide range of diseases, but their overall efficacy and safety can be
highly dependent on the presence (or absence) of native PTMs. Development in
recombinant technologies have allowed the production of some human-like protein
glycosylation patterns, however, a range of factors during the manufacturing process
can dramatically affect the downstream quality and activity of the protein. Figures
1.2 – 3 show the distribution of recombinant biopharmaceuticals currently approved
for human use, and the production systems used to grow them. The trend towards
using mammalian cell (predominantly chinese hamster ovary cell) based production
systems is increasing due to the human-like post-translational modification patterns
that can be achieved. There are concerns about the comparability in the glycosylation
profiles of the endogenous molecules and different batches of the same product
(Yuen et al., 2003), rapid batch to batch characterisation and quality control of
biopharmaceuticals is therefore of the utmost importance. Existing approaches to
characterise glycoproteins and peptides are discussed later in this chapter.
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Glycan structure
Mammalian glycans consist of 10 common monosaccharide units that are used to
build up the complex oligosaccharide structures. In contrast with nucleic and amino
acids, which only form linear structures due to presence of only one linkage site for
oligomerisation, monosaccharides can connect via any of their hydroxyl groups,
resulting in a diverse set of linkages that can form either linear or branched
structures. This is further complicated by the stereochemistry at the linkage site due
to anomericity of the reducing sugar. Two mannose residues can theoretically be
connected in 8 different configurations, although, in biological systems, only a
limited number of these linkages have been observed to occur. Additional
modification by sulfation, phosphorylation and acetylation combined with the
stereochemical and structural diversity provides a major analytical challenge.
Glycans can range from single monosaccharide subunits, to large, complex
oligosaccharides and occur in four main types: glycophosphatidylinositol (GPI)
anchors, N-linked, O-linked, and free oligosaccharides.
GPI Anchors
GPI anchors are a glycan bridge between phosphatidylinositol and
phosphoethanolamine, an amide linkage on the carboxyl terminus of a protein. Their
main role is to anchor proteins to the phospholipid bilayer of a cell membrane.
N-linked glycosylation
N-linked glycosylation is the covalent attachment of an oligosaccharide chain to an
asparagine residue in a polypeptide chain. N-glycans share a common
pentasaccharide core and can be divided in to three general classes: high mannose
type, complex type and hybrid type. The high mannose type contains only mannose
Chapter 1: Introduction
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residues beyond the pentasaccharide core, complex type glycans contain a mixture of
monosaccharide subunits, and hybrid type contain features of both complex type and
high mannose glycans. Potential N-linked glycosylation sites can be predicted from
the genome as they require a consensus sequence in the polypeptide chain of Asn-X-
Ser/Thr, where X is any amino acid except proline. Although these potential
glycosylation sites can be predicted, not all of them are occupied by glycans in vivo,
and contribute to the heterogeneous composition of glycoproteins
(microheterogeneity) (Raman et al., 2005; Budnik et al., 2006; Hossler et al., 2007).
O-linked glycosylation
O-linked glycans are frequently linked to the polypeptide via N-acetylgalactosamine
(GalNAc) to the hydroxyl group of serine or threonine residues. O-glycans can be a
single monosaccharide, or long highly sulfated structures. O-glycosylation sites
(unlike N-linked) do not have a consensus sequence that can be elucidated from the
protein primary structure.
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urrent strategies in glycan characterisation
dentifying glycoproteins
he first stage in glycan characterisation requires the identification and isolation of
lycosylated proteins.
raditional biochemical colourimetric assays for carbohydrates in solution (e.g.
enol-sulphuric acid assay) are not sensitive enough to detect the presence of glycans
t the concentrations relevant to biological systems. It has therefore been necessary
o develop more sensitive techniques to identify the presence of glycoconjugates.
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The periodic acid-Schiff staining procedure is capable of identifying the presence of
glycosylated proteins in a sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) gels, but it is not completely specific for carbohydrates and requires a
relatively large amount of protein (50- 250 µg) to be loaded on to the gel to bring the
carbohydrate concentration up to detectable levels. Fluorescent stains and markers
can be more sensitive for the detection of glycosylation, but all of these techniques
covalently modify the glycoproteins making them inadequate for the analysis of fine
structural detail, and can make quantitative analysis difficult. When a gel is stained
specifically for the carbohydrate component, numerous additional species may also
be present but would remain unstained. A common procedure which allows
characterisation of the native glycoprotein after detection is to run duplicate SDS-
PAGE gels, of which one is used for carbohydrate detection. A second is retained
and only the protein component stained, leaving the native glycan intact. The number
of glycoproteins identified using SDS-PAGE approaches can be a significant under-
representation of the total number of glycoconjugates present in a cell or tissue
lysate. This is due to the inherent challenges in solublising hydrophobic, membrane
associated proteins (Geyer and Geyer, 2006).
Lectins are carbohydrate-binding proteins that are not enzymes or antibodies, but can
bind to specific carbohydrate residues and motifs (Lis and Sharon, 1998; Sharon and
Lis, 2004) Lectin affinity chromatography is a technique which can separate and
enrich glycosylated proteins (Merkle et al., 1987). A protein or peptide mixture is
passed through the chromatography column containing lectins bound to the
stationary phase. Interaction of the carbohydrate moieties of glycocunjugates with
the lectins causes them to be retained on the column. Incubation with competing
sugar molecules can be used to elute the glycoproteins or peptides. A limitation of
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this technology is that each lectin binds a specific subset of carbohydrates. Therefore
a lectin column has a bias towards glycoproteins containing specific glycan
structures. This can result in the loss of novel glycans.
Glycan release methods
Most of the techniques for glycan analysis require the oligosaccharide to be released
from the underlying peptide. Both enzymatic and chemical methods are available to
release intact oligosaccharides for further analysis.
Enzymatic release
The most common enzymatic release of N-linked glycans is by treatment with
peptide N-glycosidase F (PNGase F) (Anthony et al., 1987). Its enzymatic activity is
specific for the cleavage of the amide bond between the GlcNAc residue and the
asparagine of the polypeptide chain. As a result of the treatment, the oligosaccharide
is released providing a free reducing terminus (which may be used for labelling and
derivatisation at a later stage), and the asparagine is converted to an aspartic acid.
PNGase F treatment is the preferred technique as it leaves the oligosaccharide and
the peptide intact for further analysis. PNGase F cannot release O-linked glycans; N-
linked glycans with an α1-6 linked fucose on the GlcNAc adjacent to the
polypeptide; or glycans on the amino- or carboxy-terminus of a peptide chain.
An alternative family of enzymes that perform oligosaccharide release are endo-β-N-
acetylglucosidases (e.g. Endo H (Trimble et al., 1987) and Endo F). These enzymes
cleave the glycosidic bond between the two GlcNAc residues at the reducing
terminus of an N-linked glycan. The point of cleavage yields an oligosaccharide
which has lost one GlcNAc residue from the reducing terminus, and the peptide with
the second GlcNAc residue still attached to the asparagine side chain.
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There is currently no enzyme with O-glycanase activity which can be used against all
O-linked glycans. Enzymatic release of O-linked glycans is not generally attempted
but can to a certain extent be achieved by sequential treatments with
endoglycosidases of different carbohydrate specificities. This may yield an intact
peptide for site mapping, but will not produce an intact oligosaccharide for complete
structure determination.
Chemical release
Two forms of chemical release have been developed to overcome the limitations of
the enzymatic release techniques: hydrazinolysis and β-elimination.
Hydrazinolysis uses anhydrous hydrazine to release both N- and O-linked glycans
(Patel et al., 1993). By varying the conditions of the reaction, it is possible to
selectively release N-linked glycans; sequentially release N- followed by O-linked;
or release all at the same time. The hydrazine treatment will cleave many of the
amide bonds in the peptide rendering it useless for further studies, and will break any
N-acyl groups in the oligosaccharide (e.g. N-acyl groups present in GlcNAc). It is
necessary to re-N-acetylate the cleaved groups using acetic anhydride. Some
structural information can be lost as a result of hydrazinolysis due to loss of
components like N-glycolyl-neuramic acid.
Alkaline borohydride treatment (β-elimination) of glycoproteins under carefully
controlled conditions can selectively release only the O-linked glycans. This release
method modifies the reducing terminus so it loses the capacity to be further
derivatised (e.g. addition of fluorescent labels). Modification of the glycosylation site
also occurs making the technique amenable to site mapping studies.
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Compositional analysis
Compositional analysis is routinely carried out using two main techniques: high pH
anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD)
(Hardy, 1994) and gas chromatography-mass spectrometry (GC-MS).
HPAEC-PAD has become a routine compositional analysis tool as it is a relatively
simple and sensitive technique and does not require the derivitisation of samples
prior to analysis. Carbohydrates typically have a high pKa values in the 12-14 range.
Monosaccharides and oligosaccharides, when placed in a sufficiently basic
environment will become negatively charged due to the formation of oxyanions. The
carbohydrate samples can be retained on an anion exchange column where they are
eluted by reducing the pH of the surrounding solution. The elution time is recorded
by pulsed amperometric detection. There is good correlation between pKa and their
elution order.
GC-MS is a sensitive technique for monosaccharide composition analysis allowing
detection of subnanomole amounts (Merkle et al., 1994). Composition analysis is
carried out by the cleavage of the oligosaccharide to give monosaccharides. The
monosaccharides are then derivatised to make volatile compounds which can then be
introduced in to the GC-MS for analysis.
Sequence analysis
Sequence information for an oligosaccharide can be obtained using a number of
techniques including exoglycosidase treatment and mass spectrometry.
Exoglycosidases are enzymes which remove sugar subunits from the non-reducing
terminals of an oligosaccharide (Jacob et al., 1994). A purified oligosaccharide is
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incubated with a high concentration of a specific exoglycosidase before being
subjected to chromatographic analysis. A change in the retention time of the
oligosaccharide can be attributed to the removal of one or more monosaccharides.
Sequential incubation and analysis can be used to perform stepwise degradation of
the glycan to provide sequence and some linkage information. This method is time
consuming and requires large amounts of purified glycan samples.
As a result of developments in instrumentation resulting in low pico- femtomolar
sensitivity, mass spectrometry is becoming a powerful tool in the analysis of
oligosaccharides. Matrix assisted laser desorption/ionisation (MALDI) mass
spectrometry (MS) offers high throughput, high mass range and contaminant
resistant profiling and composition analysis of complex mixtures of glycans. This
type of MALDI-MS experiment yields only intact masses of glycans, and cannot be
used to determine definitive composition or sequence of analysed carbohydrates.
Chromatographic separations coupled to tandem mass spectrometry can allow a
greater degree of structural information to be elucidated including the potential
identification of carbohydrate composition, sequence and stereochemistry at the
expense of analysis speed (Harvey, 2001).
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igure 1.5 shows an example workflow for characterisation of glycans from a protein
ixture. The timescale for carrying out each of these processes ranges from hours
chromatography separations), to overnight incubation (PNGase F treatment). These
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strategies have a low rate of throughput, and require relatively large amounts of
sample to perform complete glycan characterisation.
Introduction to mass spectrometry
Mass spectrometry is a powerful analytical technique that can offer both high
sensitivity and selectivity. The basic function of a mass spectrometer is to separate
ions based on their mass-to-charge ratio (m/z). This is achieved by ionisation of the
sample, separation of ions of differing (m/z) and subsequently detecting and
recording their relative abundance. A mass spectrometer is therefore comprised of an
ionisation source, an inlet, a mass analyser and a detector. Variations on each stage
allow the production of a wide range of mass spectrometers which are suitable for
different applications.
I
I
m
BFigure 1.6: A schematic block diagram of a mass spectrometer
Sections in grey are only used during tandem mass spectrometry experiments.
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onisation
onisation of analytes can be carried out in a number of ways. Common ionisation
ethods include Electron ionisation (EI), Chemical Ionisation (CI), Fast Atom
ombardment (FAB), Matrix-assisted Laser Desorption/Ionisation (MALDI),
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Electrospray Ionisation (ESI) and Atmospheric Pressure Chemical Ionisation (APCI).
Only ESI will be discussed here. A more detailed account of other methods can be
found elsewhere (de Hoffmann and Stroobant, 2007).
Electrospray Ionisation (ESI)
Electrospray Ionisation was first reported by Dole (Dole et al., 1968) in the late
1960’s, and was subject to major improvements in the 1980’s by Fenn and co-
workers (Yamashita and Fenn, 1984, 1984).
The analyte is dissolved in a volatile solvent before the solution is introduced in to
the source region by means of a conductive capillary held at high potential difference
relative to the walls of the ion source. In positive mode, the migration of positive
ions to the surface of the liquid causes an instability as Coulombic repulsive forces
overcome the liquid’s surface tension. This results in the formation of a mist of
positively charged droplets. There are a number of proposed mechanisms for the
generation of analyte ions from these charged droplets. Two main mechanisms are
the charged residue model (CRM) and the ion evaporation model (IEM).
In the CRM mechanism, solvent evaporation causes an increase in charge density at
the surface of the droplets until it reaches a critical point known as the Rayleigh
limit. At this point, the electrostatic repulsion of the ions is greater than that of the
surface tension causing fission of the droplet. The resultant smaller droplets undergo
multiple rounds of desolvation and fission until droplets containing only one solute
molecule are formed. Analyte ions are then ejected in to the gas phase by
electrostatic repulsion (Dole et al., 1968).
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The IEM mechanism proposes that, as the solvent evaporates from the charged
droplets, it becomes electrostatically favourable for analyte ions evaporate from the
droplet surface (Iribarne and Thomson, 1976).
The ions then enter the analyser region via a sampling orifice.
M
T
C
t
o
t
Q
T
m
sFigure 1.7: Electrospray ionisation process
Modified from (de Hoffmann and Stroobant, 2007)
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ass analysers
he mass analyser is the second major variable in the design of a mass spectrometer.
ommon mass analysers include ion traps, Orbitraps, time-of-flight (TOF), Fourier
ransform ion cyclotron resonance (FTICR), and quadrupoles. Quadrupole and time-
f-flight analysers will be discussed here, detailed descriptions of other analyser
ypes can be found elsewhere (de Hoffmann and Stroobant, 2007).
uadrupole
he quadrupole analyser (Paul and Steinwedel, 1953) (also known as a quadrupole
ass filter) is a scanning analyser, producing a mass spectrum by sequentially
canning individual mass-to-charge ratios over a selected range.
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The quadrupole comprises four cylindrical metal rods held in parallel in a square
array. Ions generated in the source region of the instrument are transported in to the
space between the rods. A direct current (DC) voltage and a radio frequency
alternating current (AC) voltage (often referred to as the RF voltage) is applied to
each diagonally opposed pair of rods. Each pair of rods receives a voltage of the
same amplitude but opposite sign. This results in an electrostatic field which causes
ions to oscillate in the x and y directions, while they traverse the length of the
quadrupole region (z). For a set DC/RF voltage, only ions of a specific m/z will be
transmitted through the quadrupole region as they will maintain a stable oscillating
trajectory. Ions outside of this m/z range have unstable trajectories and will undergo
collisions with the quadrupole rods resulting in neutralisation of the ions.
A mass spectrum is obtained by increasing the RF and DC voltages simultaneously
permitting ions of increased m/z to traverse the quadrupole to the detector. The
intensity of the ion signal at the detector is then plotted versus the m/z being
transmitted by the quadrupole.
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uadrupole analysers can be used in RF mode only. This allows all ions above a
ertain m/z (determined by the amplitude of the RF voltage) to traverse the
uadrupole region. Ions transmitted in this way are systematically focused to the
entre of the space between the rods, even after deflection due to collision with other
ons. The resultant focussing effect is important for improving the transmission of
ons after collisions.
ime of Flight
nitially conceived as a linear analyser and first produced as a commercial instrument
n this form (Wiley and McLaren, 1955). The development of the TOF analyser and
ence its use in mainstream applications was significantly delayed until the early
980’s. There was a renewed interest in the technology when faster electronics
ecame available that could be capable of handling the flow of data from the
nalyser.
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Packets of ions (produced either by a pulsed ionisation source, or a transient
application of focusing lenses) are introduced from the source region. The ions are
accelerated by a potential (Vs) and traverse a field-free region of a known distance (d)
before reaching the detector. The time taken for the ions to travel the length of the
field-free region (t) is converted to a mass-to-charge ratio using the relationship:
ݐଶ = ݉
ݖ
ቆ
݀ଶ2 ௦ܸ݁ ቇ
1.1
Benefits of this type of mass analyser include a potentially unlimited upper mass
range, and very high sensitivity due to the high transmission efficiency. The main
drawback of a linear TOF is a low resolution compared with some other analysers.
This reduced resolution is due to a number of factors including the duration of the
ion pulse, the volume of the ion packet and the initial kinetic energy of the ions.
The different initial kinetic energies of the ions results in different velocities for ions
of the same m/z. The resultant spread of arrival times causes broadening of the mass
spectral peak. One method of overcoming this problem is the use of a reflectron. A
reflectron is comprised of a series of ring electrodes which act as an ion mirror,
deflecting the packet of ions back in to the field-free flight tube, slightly off their
original axis. This has two benefits for resolution, firstly, the distance travelled in the
field-free region is doubled, causing better spatial separation of ions of different m/z
and secondly, the correction of the kinetic energy dispersion of ions of the same m/z.
Ions with greater initial kinetic energy will have a higher velocity. When they
encounter the electrostatic field of the reflectron, they will penetrate deeper than an
ion of lower kinetic energy. The reflected ions of the same m/z then have the same
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arrival time at the detector. This increase in resolution is however at the expense of
some sensitivity and the introduction of a kinetic energy range limitation.
An additional method for reducing the spread of initial kinetic energies of ions before
analysis in a TOF, is to use delayed pulsed extraction. It is more commonly used in
instruments with pulsed ion sources (e.g. MALDI). Immediately after formation, ions
are allowed to expand in to a field free region in the source. After a delay of up to
several microseconds, a voltage pulse is applied to an electrode grid to extract the
ions from the source region. This helps to even out the kinetic energy spread of the
ions as those that have spent longer in the source region receive more energy than
those that have travelled further from the extraction electrode (Vestal et al., 1995).
For a TOF analyser to be coupled to a continuous ion source such as ESI, an
interface for sampling the ion beam must be used. Orthogonal injection can be used
to generate packets of ions which are directed off axis from the source beam to a
detector or reflectron (Dawson and Guilhaus, 1989). Ions enter a field-free region of
the orthogonal accelerator before a transient injection voltage is applied to a pusher
plate. The ions then traverse the field-free flight tube (via a reflectron, if present) to
the detector. In practice, the pulsed electric field applied to the pusher plate operates
at a frequency of several kilohertz. Any ions not sampled to the analyser are lost.
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tors
s types of detector can be used to detect ions after mass separation. Some
ors that have been employed include: photographic plates, Faraday cups,
n multipliers, photon multipliers and array detectors.
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A widely used detector is a microchannel plate (MCP). An MCP is made of an array
of small electron multiplier channels, approximately 4-25 µm in diameter and a few
millimetres long. The input side of the plate is held at -1 to 2 kV relative to the
output side. Ions collide with a conversion dynode on the surface of the plate. The
dynode emits electrodes which are directed in to the channels by a semiconductor
coating. The channels act as continuous dynodes resulting in the multiplication of
electrons. Amplifications in electron numbers of 104 can be achieved by a simple
channel or up to 108 with the use of multiple plates. The cascade of electrons is
collected at an anode and the current measured. A single ion will only activate a few
channels so it is possible to detect multiple ions simultaneously. The MCP channels
require a period of time to recover after detecting an ion before they can be activated
again (dead time). It is therefore important to not saturate the detector with signals as
subsequent ions may not be detected.
Data systems
A modern mass spectrometer generally has a data system which is required for
control of the mass spectrometer, and acquisition and processing of the data recorded
by the mass spectrometer. A data acquisition system is required to convert analogue
signals recorded by the mass spectrometer in to digital signals that can be processed
by the data system. Different data acquisition systems are used in different types of
mass spectrometer.
Analogue to digital converter
An analogue to digital converter (ADC) is commonly used in conjunction with
scanning analysers like quadrupoles. An ADC records the amplitude of the voltage
from the detector at regular time intervals. The sampling frequency of the ADC
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depends on the scan speed of the mass analyser (mass range per unit time) and the
desired resolution. If scan speed or resolution is increased, the sampling rate of the
ADC must be increased. For a quadrupole scanning 1000 mass units in 1 s, with 10
data points per peak, the sampling frequency must be at least 10 kHz. The sampling
frequency required for TOF instruments (capable of 50 mass units in 1 µs) must be at
least 500 MHz. As the volume of data is dependant on the number of data points
recorded, and not number of ions detected, the rate of data transfer and data storage
capacity requires the use of a summing memory which accumulates data for a period
of time before forwarding to the data system.
Time to digital converter
An alternative method of converting analogue signals to digital signals which is often
used in a TOF instrument is a time to digital converter (TDC). In contrast with an
ADC which records voltage at a regular sampling frequency, a TDC counts voltage
pulses that exceed a set amplitude threshold, and records the start and end time of the
pulse. The list of recorded times are stored in a histogram memory. The volume of
information transferred from the histogram memory is relatively small as the size of
the list is proportional to the number of ions detected in that TOF cycle. The
histogram memory can be used to sum the detected events from a number of flight
cycles. As the TDC is a counting device, if two or more ions arrive at the detector
simultaneously in one flight cycle, only one pulse is counted. This is also true for two
ions arriving in rapid succession, as the TDC has a counting dead time after each ion
event before it can register another count. Saturation of the detector in this way
results in a reduction in mass accuracy. It is therefore more suited to applications
detecting small quantities of ions for a long period of time.
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Tandem Mass Spectrometry
Single mass analyser mass spectrometers can be used to measure the molecular mass
of an analyte, but if greater structural information is to be obtained, a tandem mass
spectrometry experiment must be performed. Tandem mass spectrometry (MS/MS)
couples two mass analysers, of the same or different types, allowing the isolation and
fragmentation of selected m/z species in the first analyser and mass separation and
detection using the second analyser.
A common method of fragmentation carried out in MS/MS experiments is collision-
induced-dissociation (CID) (Jennings, 1968). Ions of selected m/z (precursor ions)
enter a collision cell containing inert gas molecules. Collisions with the gas
molecules cause the ions to fragment in to a mixture of product ions and neutral
fragments. The product ions are then analysed.
MS/MS experiments of two types can be performed, these are referred to as: in-space
and in-time. An in-time experiment can be carried out in a mass analyser capable of
trapping ions e.g. ion trap. RF and DC fields are applied to select an ion of a given
m/z. Fragmentation of the ions can then be carried out by a number of methods
including electron capture dissociation (ECD) (Zubarev et al., 1998), electron
transfer dissociation (ETD) (Syka et al., 2004), infrared multiphoton dissociation
(IRMPD), CID and others. The fragments are analysed by the same analyser.
In-space experiments use instruments where the mass analysers are arranged in
sequence. An example of one of these instruments is a quadrupole – time-of-flight
(Q-TOF) instrument. In a Q-TOF, ions of a particular m/z are selected by the
quadrupole. The precursor ions undergo CID in a collision cell containing an inert
gas such as argon. The product ions are then transmitted to the TOF analyser.
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Ambient mass spectrometry
Ambient mass spectrometry is described as mass spectrometric analysis with no or
minimal sample preparation, using direct sampling and ionisation at ambient
conditions (Venter et al., 2008). Since the introduction of desorption electrospray
ionisation (DESI) in 2004 (Takats et al., 2004) there have been a number of other
ambient ionisation sources developed including: direct analysis in real time (DART)
(Cody et al., 2005), desorption atmospheric pressure chemical ionisation (DAPCI)
(Takats et al., 2005), atmospheric pressure solids analysis probe (ASAP) (McEwen
et al., 2005), extractive electrospray (EESI) (Chen et al., 2006), and neutral
desorption extractive electrospray (ND-EESI) (Chen et al., 2007). A comprehensive
list of current ambient ionisation sources can be found in Table 1.
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ESI related ambient ionisation sources
Desorption electrospray ionisation
DESI is a variation on ESI whereby the analyte sample is not pre-dissolved in the
ESI solvent, but is instead held in the path of the ESI spray between the capillary and
the source inlet. A suggested mechanism for ionisation during a DESI experiment
has been proposed by Venter et al. (Venter et al., 2008). Aqueous droplets less than
10 µm in diameter impact the sample surface. Initial droplets pre-wet the surface
causing analyte molecules to dissolve. Later-arriving droplets impact the surface
solvent layer resulting in its disruption and formation of offspring droplets containing
dissolved analyte. Charging of the analyte molecules then progresses by ESI
mechanisms.Figure 1.10: A schematic of the DESI ambient ionisation source
Modified from (Cooks et al., 2006).
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Non destructive sampling of a wide variety of surface types including: glass,
cardboard, paper, leather and skin has been achieved. Using a confined diameter
solvent beam, it is possible to obtain spatially resolved chemical information with
DESI, allowing sensitive imaging under ambient conditions (Venter et al., 2008).
DESI imaging of phospholipids in rat brain tissue sections has been achieved with a
spatial resolution of < 500 µm. The advantages of DESI imaging compared with the
existing MALDI imaging technique are higher throughput, and no requirement to
pre-treat the surface with matrices. The disadvantages of the DESI imaging approach
are lower spatial resolution (250 – 500 µm compared with 25 – 200 µm in MALDI
imaging (Liam and Ron, 2007)), and only the surface or near-surface compounds
will be analysed as the solvent beam does not penetrate in to the sample.
Extractive electrospray ionisation and neutral desorption extractive
electrospray ionisation
EESI and the closely related ND-EESI also use an ESI related setup for ambient
sample analysis. Both techniques use a nitrogen gas flow directed at a sample to
generate an aerosol of N2 and analyte molecules. For EESI, the sample is a liquid or
volatile compounds in an enclosed vessel. ND-EESI samples exposed surfaces, either
solid or liquid. The analyte aerosol is the sampled in to the desolvation gas line of an
un-modified ESI source (Chen et al., 2007). ESI solvent is ionised at the capillary tip
before it is allowed to mix with the desolvation gas/analyte aerosol. The precise
mechanism of ionisation of the analyte molecules is not currently known, however it
has been proposed that analytes are extracted from neutral droplets, into charged
droplets where the then encounter an ESI-like mechanism.
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PCI related ambient ionisation sources
PCI is an ionisation method that uses gas-phase ion-molecule reactions at
tmospheric pressure to generate charged analyte ions. Analytes dissolved in a
olvent are nebulised by nitrogen at a high flow rate. Droplets are then heated
ausing evaporation of the solvent. The hot gas and sample leave the source probe
nd are directed to a corona discharge electrode. Ionisation occurs due to proton
ransfer or adduct formation from neutral metastable molecules formed in the electric
ield.
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Direct analysis in real time
The DART source uses the flow of helium gas through a corona discharge field to
form reactive species used to ionise analyte molecules. In the proposed mechanism
by Cody et al., metastable helium atoms are generated when the gas is passed
through the corona discharge field. These neutral metastable atoms react with
ambient water and oxygen to produce ionising species which are carried to the
sample surface by a stream of heated gas. Analyte ions generated by reaction with
the ionising species are then sampled in to the mass spectrometer (Venter et al.,
2008).
D
I
n
a
mFigure 1.12: A schematic of the DART source
Modified from (Cooks et al., 2006).
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esorption atmospheric pressure chemical ionisation
n DAPCI, a solvent is nebulised and heated as with APCI. The stream of heated
itrogen gas and solvent vapour are then directed over the sample surface where
nalyte molecules are thermally desorbed in to the gas phase. The gaseous analyte
olecules are then ionised in the corona discharge field by an APCI like mechanism.
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Atmospheric solids analysis probe
ASAP is a thermal desorption method similar to that in DAPCI. Molecules on the
sample surface are desorbed using a stream of heated nitrogen gas without any
additional solvent. The analyte molecules are subsequently ionised in the corona
discharge field and then sampled in to the mass spectrometer.
Ion mobility spectrometry
Ion mobility spectrometry is an analytical technique currently employed for the
detection of drugs, explosives and chemical warfare agents. The ion mobility
approach uses the migration of analyte ions under the influence of an electrostatic
field through a drift cell containing an inert buffer gas. Separations of the ions result
from interactions with the buffer gas. The separation is dependant on the mass,
charge and shape of the analyte ion.
Ion mobility spectrometry can be carried out in three different methods: drift cell ion
mobility spectrometry (DCIMS), high-field asymmetric wave form ion mobility
(FAIMS), and travelling wave ion mobility spectrometry (TWIMS). A description of
FAIMS can be found elsewhere (Guevremont and Purves, 1999).
DCIMS
DCIMS separates ions based on their different velocities attained when accelerated
through a drift tube, filled with a neutral gas, by a constant electric field (E) (Cohen
and Karasek, 1970). The drift tube has a constant electric field generated by a series
of electrodes. An ion achieves a quasi-constant velocity (vd) due to the acceleration
by the field, and retardation by collisions with the neutral gas. The ion mobility (K) is
the ratio of vd to electric field strength E.
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ܭ = ݒௗ
ܧ
1.2
The ion mobility is usually expressed as reduced mobility (K0) which is the mobility
of the ion at standard temperature and pressure (P0 of 760 Torr and T0 of 273.15 K)
so that:
ܭ଴ = ܭ ܲ ଴ܶ
ܶ ଴ܲ
= ܭ ܲ× 273.15
ܶ× 760
1.3
Using kinetic theory (Edward and Earl, 2005), the reduced mobility K0 can be related
to the collision cross section of the ion species by the following equation:
ܭ଴ = 3݁ݖ16ܰ଴ × 1ߪඨ൬ 2ߨߤ ஻݇ ܶ൰
1.4
Where z is the number of charges, e is the electronic charge, N0 is the buffer gas
number density at standard temperature and pressure, µ is the reduced mass of the
buffer gas and the ion, kB is Boltzmann’s constant, T is the effective temperature and
σ is the average collision integral or collision cross section. The average collision
cross section can be obtained by averaging all possible collision geometries
(Clemmer and Jarrold, 1997). Exact calculation of an average collision cross section
is not trivial and many models have been proposed (Lee et al., 1995; von Helden et
al., 1995; Wessel et al., 1996; von Helden et al., 2002). Approaches pioneered by
Bowers and co-workers have been used to relate theoretical average collision cross
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sections with those obtained experimentally. This approach uses molecular dynamics
calculations to generate three-dimensional structures of molecules, minimising these
structures to determine lowest-energy conformation of these molecules, and using
programs (Wyttenbach et al., 1997) to calculate theoretical cross sections. These
calculations have been shown to be in good agreement with experimental
observations (Wyttenbach et al., 1996).Source Detector
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Figure 1.13: A representation of DCIMS
The two green ions have the same m/z but different cross sections. The more
compact ion encounters fewer interactions with the buffer gas (purple) than the
extended ion. This results in a greater velocity, and earlier arrival time at the36
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DCIM-MS
Ion mobility (IM) has been coupled with a range of mass spectrometers. Ionisation
sources including ESI (Wittmer et al., 1994; Wu et al., 1998) and MALDI (von
Helden et al., 1995) have been used to generate ions for IM analysis. Mass analysers
including quadrupoles (Shelimov et al., 1997), TOF (Srebalus et al., 1999), and
FTICR (Bluhm et al., 2000) have been used to perform mass analysis after IM
separation.
DCIMS approaches have been used to study a wide variety of molecules including
polymers (Wyttenbach et al., 1997; Gidden et al., 2002), peptides (Wyttenbach et al.,
1996), proteins and nucleic acids (Gidden and Bowers, 2003).
The main limitation of DCIM-MS instruments described to date is a lack of
sensitivity and ease of use. All instruments described have been constructed by
research groups and so have limitations compared to commercial alternatives.
TWIMS
In comparison with DCIMS, where a constant electric field is applied to the drift
tube, travelling wave ion mobility spectrometry (TWIMS) uses a travelling voltage
wave to propel ions through a mobility cell containing neutral gas molecules. The
travelling wave (T-Wave) is generated by applying transient DC voltages to
electrodes in a stacked ring ion guide (SRIG). A SRIG is composed of a series of
ring electrodes that are arranged orthogonally to the axis of ion transmission.
Opposite phases of RF voltage are applied to pairs of adjacent electrodes. This
generates a radially-confining potential barrier preventing ion loss by diffusion to the
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wall of the SRIG. Ions are propelled through the SRIG by superimposing a DC
potential on the RF potential applied to one pair of adjacent electrodes. This potential
moves along ring electrode pairs across the length of the SRIG at regular time
intervals generating a series of T-Waves. A SRIG operated in this configuration will
be referred to as a travelling wave ion guide (TWIG).
TWIM-MS
The Synapt HDMS (high definition mass spectrometry) system (Waters corp.,
Milford, USA) is the first commercial instrument to incorporate ion mobility
separation.
T
m
b
tFigure 1.14: Schematic of the Waters Synapt HDMS instrument
From: (Pringle et al., 2007)38
he Synapt HDMS incorporates a series of three TWIGs (‘TriWave’ device) for ion
obility separation within a Q-TOF instrument. The ‘TriWave’ device is positioned
etween the quadrupole and the (oa)-TOF. The first TWIG is referred to as the trap,
he second is the ion mobility separator (IMS), and the third is the transfer TWIG.
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The finial electrode pair of the trap TWIG is DC-only. When the voltage is raised, it
does not allow the passage of ions, causing them to accumulate in the TWIG. At the
start of an ion mobility separation cycle, the amplitude of the voltage on this gate is
lowered, typically for 100 µs, releasing a packet of ions in to the IMS region for
separation. The transfer TWIG maintains the mobility separation of the ions while
delivering them to the oa-TOF.
The IMS region of the Synapt HDMS is at high pressure relative to the other regions
of the instrument. It can be operated at pressures of up to 1 mbar using a range of
gases (but most commonly, nitrogen). The T-Wave in this region has a repeat pattern
of 6 electrode pairs which means that the DC pulse is applied to the 1st and 7th pairs
of electrodes, then it is applied to the 2nd and 8th pairs etc. The velocity of the wave is
derived from the distance between electrode pairs divided by the time the DC pulse
remains in each pair. The velocity is given in metres per second and the operating
range is from 200 to 600 m s-1.
Mobility separation of ions is achieved because ions with high mobility are driven
through the IMS region by the T-Wave and exit faster. Ions with a lower mobility
roll over the wave top and require subsequent waves to propel them further resulting
in a later exit time. The amplitude of the T-Wave voltage (T-Wave height) must be
optimised to ensure all ions from a single packet exit the mobility separator before
the next packet is injected, while maintaining sufficient mobility separation of the
ions.
To record the arrival time distribution (ATD) of the mobility separated ions, the
oa-TOF acquisition is synchronised with the gated release of ions from the trap
TWIG in to the mobility cell. For each packet of ions, 200 orthogonal axis pushes
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(mass spectra) of the TOF analyser are recorded. The overall mobility separation
time is: 200 × tp where tp is the pusher period. 200 mass spectra obtained from the
next packet of ions are added to the data from the previous gated release. This is
repeated until a desired signal-to-noise ratio for the mass spectrum is obtained.
The major advantage of this method of mobility acquisition is the recording of both
arrival time information and mass spectral data of all ions in the mass spectrum.
Tandem MS on the Synapt HDMS
An additional feature of the Synapt HDMS instrument is the ability to perform CID
in the trap and/or transfer TWIGs, with or without prior m/z selection on the
quadrupole. This allows: i) the mobility separation of product ions (trap only CID),
ii) fragmentation of mobility separated ions (transfer only CID), iii) and an MS3
experiment where ions are fragmented in the trap, product ions are mobility
separated, and further fragmentation performed in the transfer TWIG.
The advantages of this type of instrument configuration include: i) high sensitivity.
Introduction of the TriWave device does not compromise sensitivity of the Q-TOF
instrument. ii) Excellent reproducibility. The reproducibility is better than ± 1 scan
(in the 200 collected per ion packet injection). iii) Versatility. The ability to perform
a range of mobility and MS/MS experiments provides an analytical technique of
significant flexibility.
The major limitation of the Synapt HDMS instrument is the inability to directly
calculate average collision cross sections from the measured drift times. Cross
section estimation is however possible using calibration standards with established
cross sections.
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Cross section calibration
The path taken by an ion traversing the mobility cell in a TWIMS device is complex
and, currently, not fully understood. Therefore, the direct calculation of average
collision cross sections for ions of interest is not possible. The calibration of the
TWIMS device to obtain estimated average collision cross sections has been
demonstrated (Ruotolo et al., 2005; Wildgoose et al., 2006; Ruotolo et al., 2008;
Scarff et al., 2008; Williams and Scrivens, 2008; Thalassinos et al., 2009).
A detailed method for the cross section calibration can be found in Chapter 3. The
most common calibration approach relies on using the Synapt HDMS to measure the
mobility of compounds of known cross section values, and to derive estimates of
cross section of unknown compounds from a calibration curve.
Aims and objectives
The development of new ambient ionisation sources and travelling-wave-based ion
mobility mass spectrometry experiments have resulted in improved approaches for
the analysis of a range of compound classes.
The requirement for rapid, sensitive and selective analysis of carbohydrates and
glycoconjugates is increasing due to the greater understanding of their significance in
biological systems, and their increased use as therapeutic agents.
This project focused on evaluating the use of selected ambient ionisation approaches
in the analysis of pharmaceutical formulations, and investigating the potential of
shape selective separations in the analysis of carbohydrates.
The aims of the project were to:
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Assess the amenability of recently developed ambient ionisation approaches to the
analysis of a range of pharmaceutical formulations, including the glycosylated anti-
biotic: erythromycin (Chapter 2). Improvements in the rate of sample analysis could
provide a method of rapid batch to batch characterisation of small molecule
pharmaceuticals.
Investigate the shape selective separation of two isomeric glucose polymers, (dextran
and maltodextrin) ionised using a range of alkali metal cations, using a recently
commercialised travelling-wave-based ion mobility mass spectrometer. Arrival time
data obtained from the ion mobility separation will also be used to generate estimated
collision cross sections for the molecules (Chapter 3).
Employ the shape selective separation potential of the Synapt HDMS in the rapid
analysis of glycans released from glycoproteins and oligosaccharides commonly
found in milk (Chapter 4). Rapid, reproducible ion mobility separations of glycan
mixtures could result in a method of obtaining glycosylation profiles for individual
proteins or protein mixtures in biopharmaceutical analysis or diagnostic testing.
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Introduction
A significant process in mass spectrometry based techniques is the generation of gas
phase ions from a sample, and introducing them in to the mass spectrometer for
analysis. Ionisation methods such as ESI and MALDI have helped to address the
problems associated with ionising a range of compound classes including small
molecules, lipids, carbohydrates, nucleic acids and proteins.
The recent development of a family of ambient ionisation techniques can allow the
formation of gaseous ions under ambient conditions with minimal sample pre-
treatment and can, in many cases, be performed on existing commercial instruments
without significant modifications to hardware or software.
There has been rapid growth and continued interest in ambient mass spectrometry
since DESI was first reported in 2004, with the development of more than twenty
new ionisation sources being reported in the past five years.
Presented here are a series of experiments performed during a period of technique
and application development immediately following the initial publications of some
of the new ionisation sources.
Aspects of this work have been peer reviewed and published as the following article:
Williams, J. P., Patel, V. J., Holland, R. and Scrivens, J. H. (2006). "The use of
recently described ionisation techniques for the rapid analysis of some common
drugs and samples of biological origin." Rapid Communications in Mass
Spectrometry 20(9): 1447-1456.
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Aims
The aims of this work were to:
Evaluate the novel ambient ionisation sources: DESI, DAPCI, DART and ND-EESI
and their potential applications in analysing a range of polar and weakly-polar, solid
and ointment pharmaceutical formulations.
Couple DESI and DAPCI with accurate mass tandem mass spectrometry experiments
to enhance the information content acquired for more confident assignments of
observed fragments of unknown structure.
Use DESI, and DAPCI to detect the use of pharmaceutical drugs by detection after
topical application, or oral administration with no sample pre-treatment.
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Materials and Methods
Pharmaceuticals used in this investigation and their active ingredients are listed in
Table 2.1.
Table 2.1: Pharmaceutical formulations and their active ingredients
Pharmaceutical
formulation
Manufacturer Active ingredients
Tablets
Anadin Extra Wyeth consumer healthcare (UK)
300 mg aspirin
45 mg caffeine
200 mg paracetamol
Solpadeine Max
GlaxoSmithKline
(UK)
12.8 mg codeine phosphate
500 mg paracetamol
Ibuprofen Galpharm Healthcare Ltd (UK) 500 mg ibuprofen
Metoclopramide Sanofi-Aventis (UK) 10 mg metoclopramide
Erythromycin Concept medical (UK) 500 mg erythromycin
Gels and ointments
Ibuprofen The mentholatum company Ltd. (UK) 5% w/w ibuprofen
Proctosedyl Sanofi-Aventis (UK)
0.5% w/w chinchocaine
0.5% w/w hydrocortisone
Solvents: acetonitrile, methanol, formic acid and water were obtained from Sigma-
Aldrich (Poole, UK).
Dry tobacco was obtained from a Marlboro Red cigarette (Philip Morris USA).
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DART
DART experiments were carried out on an AccuToF LC TOF mass spectrometer
(JEOL, Peabody, MA, USA). A detailed description of the DART source can be
found elsewhere (Cody et al., 2005). The DART source was operated using helium
gas and a corona discharge voltage of 2 kV to generate metastable reactive species to
promote positive ionisation of samples. Orifice 1 of the source interface was set to
27 eV. This voltage can be increased or decreased to promote or reduce
fragmentation of analyte ions. The gas temperature was maintained at 80 ºC. The
operating resolution of the instrument was approximately 6000 (full width at half
maximum (FWHM)), and mass spectra were acquired over a m/z range of 50 – 500 at
a rate of 0.5 spectra s-1. For sample analysis, the helium gas flow was directed
towards the sample surface before being sampled in to the mass spectrometer.
DESI
DESI experiments were performed on a Q-TOF I instrument (Waters, Manchester
UK). The Q-TOF I was operated in positive and negative mode with a capillary
voltage of 3.5 kV and -3.2 kV respectively. The ion source block and nitrogen
desolvation gas temperatures were set to 100 ºC and 400 ºC. The desolvation gas was
set to a flow rate of 300 L h-1. A cone voltage of 20 V was set for MS and MS/MS
experiments. The collision energy used for MS/MS experiments was ramped
between 10 and 25 eV during the acquisition. The TOF mass analyser was operated
at a resolution of 6000 (FWHM), spectra were acquired over a m/z range of 50-500
or 50-1000 with an acquisition rate of 1 spectrum s-1. For MS/MS experiments, argon
was used as the collision gas. Samples were held with tweezers at an angle of
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approximately 45 º to the solvent spray and a distance of 5 mm from the source
sampling cone.
The solvent used in negative mode was acetonitrile/H2O (1:1), with
acetonitrile/H2O + 0.2% formic acid being used in positive mode. All solvents were
infused at a rate of 10 µL min-1 using a model 22 syringe pump (Harvard Apparatus,
South Natick, MA, USA). No extensive modification of solvents, buffers or pH was
carried out.
DAPCI
DAPCI experiments were carried out on the Q-TOF I in both positive and negative
modes of ionisation. The corona discharge pin was set to 3.5 kV and -3.0 kV in
positive and negative modes respectively. The cone voltage was optimised between
10 and 25 V for each sample. The collision energy used for MS/MS experiments was
ramped between 10 and 25 eV during the acquisition. The flow rate of nitrogen
desolvation gas was set to 150 L h-1. The source and probe temperatures were set to
100 ºC and 400 ºC respectively. A solvent mixture of methanol and H2O (1:1),
flowing at 10 µL min-1 was infused in to the heated nebuliser probe where it was
converted in to an aerosol. This aerosol was rapidly heated in a stream of nitrogen
gas forming a vapour at the probe tip. The probe tip directly faced the sample surface
positioned between the corona discharge pin and the sampling cone. Reagent ions
formed in the corona discharge region reacted with desorbed analyte molecules from
the sample surface to produce predominantly protonated or deprotonated molecular
ions depending on ionisation mode.
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Solventless DAPCI
The same protocol for DAPCI was followed, but the experiments were performed
with no solvent flowing in to the heated probe. This is similar in setup to the ASAP
experiment previously described (McEwen et al., 2005).
ND-EESI
ND-EESI experiments were performed on a Q-TOF Ultima API US (Waters,
Manchester, UK). All instrument conditions were the same as those used for DESI
experiments. To perform neutral desorption sampling, a break in the nitrogen
desolvation gas line was introduced. Nitrogen gas from this line was directed at the
sample surface. Nitrogen and desorbed species from the sample surface were
sampled in to the ESI probe through the remaining section of the desolvation gas
line. The ESI solvent used in positive mode was methanol/H2O + 0.1% formic acid.
Sample Preparation
Minimal sample pre-treatment was carried out. Tablet formulations were broken in
half to expose a fresh, uncoated surface for analysis.
Gels, ointments and liquids were spotted on to matt finish cardboard or filter paper
before being introduced to the ionisation source.
Accurate Mass Measurement on the Q-TOF I
Instrumental mass drift was corrected for using a single internal reference lock mass
in MS and MS/MS mode. As the analyte compounds are known molecules, the
precursor ion selected for MS/MS experiments provided the internal reference lock
mass. Data acquisition and processing were carried out using the digital dead-time
correction algorithm embedded in the operating software, MassLynx V3.5 (Waters,
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Manchester, UK). High ion counts generated during DAPCI and DESI techniques
caused TDC dead-time saturation. The TDC correction software was used to display
centroided peaks with the correct m/z and signal intensity.
Results and Discussion
An investigation in to the amenability of ambient ionisation techniques to the rapid
analysis of active ingredients in a number of formulations has been carried out. Four
pharmaceutical tablets and two ointments have been analysed by means of DART,
DESI, DAPCI and solventless DAPCI. One tablet formulation (erythromycin) has
been analysed by DESI and ND-EESI.
In addition, human skin and urine were analysed post topical-application and
injestion of a non-steroidal anti-inflammatory (NSAID) drug.
Accurate mass MS/MS experiments have also been carried out to confirm the
identity of active ingredients.
Mass spectra with a suitable signal to noise ratio for interpretation were acquired, in
most cases in less than 5 s.
Anadin Extra
Anadin Extra is a tablet formulation containing aspirin (an antipyretic, anti-
inflammatory and analgesic), paracetamol (analgesic and antipyretic) and caffeine (a
central nervous system stimulant).
Positive mode mass spectra for Anadin Extra ionised by DAPCI, DESI and DART
are shown in Figure 2.1A-C. The protonated molecules for each active ingredient:
caffeine (m/z 195), paracetamol (m/z 152) and aspirin (m/z 181) were all observed by
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DESI and DAPCI, but the protonated aspirin species was absent from the DART
spectrum. The base peak in all spectra was due to caffeine.
Accurate mass measurement has been used to confirm the molecular formulae of the
m/z 163 ion, present in all three spectra, to correspond to that formed by loss of H2O
from protonated aspirin. DESI and DAPCI spectra contained ammoniated aspirin
[M+NH4]+ at m/z 198, and sodiated aspirin [M+Na]+ at m/z 203 present only in the
DESI spectrum.
The accurate mass MS/MS spectrum of caffeine (ionised by DAPCI) is shown in
Figure 2.1D. Elemental composition assignments for product ions observed are
presented in Table 2.2.Figure 2.1: Positive mode mass spectra of Anadin Extra by A) DESI,
B) DAPCI and C) DART, and D) accurate mass MSMS of protonated
caffeine63
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Table 2.2: Accurate masses of some DAPCI-MS/MS generated fragments of
protonated caffeine
Measured mass Molecular formula Error (ppm)
138.0675 C6H8N3O 5.8
121.0293 C7H5O2 2.5
C5H3N3O 14.0
110.0729 C5H8N3 10.0
Solpadeine Max
Solpadeine Max is a compound analgesic containing codeine phosphate and
paracetamol and is used for the relief of minor pain. Codeine is an alkaloid opiate
that has analgesic properties.
Positive mode mass spectra of Solpadeine Max ionised by DESI, DART and DAPCI
are shown in Figure 2.2 A-C. Protonated paracetamol (m/z 152) and protonated
codeine (m/z 300) are present in all three spectra. A paracetamol dimer [2M+H]+ (m/z
303) is also present in all three spectra, and its formation is related to the area of the
sample surface analysed. The ratio of monomer and dimer species can vary by the
region of the tablet presented to the ionisation source.
Table 2.3: Accurate masses of some DAPCI-MS/MS generated fragments of protonated
codeine
Measured mass Molecular formula Error (ppm)
266.1196 C17H16NO2 5.6
225.0922 C15H13O2 2.6
215.1094 C14H15O2 10.2
199.0765 C13H11O2 3.0
183.0800 C13H11O -5.4
Chapter 2: Ambient Ionisation of Pharmaceuticals
The MS/MS spectrum of codeine is shown in Figure 2.2 D. The product ion
spectrum for protonated codeine is complex, but reproducible. The proposed
formulae for some of the product ions observed are presented in Table 2.3.
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cFigure 2.2: Positive mode mass spectra of Solpadeine Max by A) DAPCI-MS,
B) DESI-MS and C) DART-MS, and D) accurate mass MSMS of protonated
codeine65
etcolopramide
etoclopramide is an antiemetic and gastroproxinetic that is predominantly used to
reat nausea, vomiting and to facilitate gastric emptying in patients with
astroparesis.
etoclopramide has been analysed using DAPCI in both positive ion, and negative
on modes. Positive mode DART spectra have also been acquired.
he deprotonated molecular species has been observed in negative mode (m/z 298
nd 300) with signal intensities in a ratio of 3:1, consistent with the presence of a
hlorine atom Figure 2.3 A. The protonated active ingredient (m/z 300 and 302) was
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the base peak in both DAPCI and DART positive mode mass spectra Figure 2.3 B
and E.
Accurate mass MS/MS of metoclopramide has been performed on both the [M+H]+
and [M-H]- species. The spectra are displayed in Figure 2.3 C and D. The elemental
composition assignments for some product ions are presented in Tables 2.4 and 2.5.
The deprotonated molecule appears to fragment by the unusual loss of a methyl
radical, resulting in the formation of an odd-electron radical anion of m/z 283. This
ion undergoes further fragmentation to m/z 211, the loss of the diethylamine moiety
(confirmed by accurate mass measurement).
Figure 2.3 D shows the accurate mass MS/MS spectrum obtained for protonated
metoclopramide. The spectrum shows ions at m/z 227 and 184, in agreement with
results published from liquid chromatography-tandem mass spectrometry (LC-
MS/MS) studies of this compound (Abdel-Hamid and Sharma, 2004).
Chapter 2: Ambient Ionisation of PharmaceuticalsFigure 2.3: DAPCI-MS spectra of metoclopramide in A) negative ion, B)
positive ion. Accurate mass DAPCI-MSMS spectra of C) deprotonated, and
D) protonated metoclopramide. E) Positive ion DART-MS spectrum of
metoclopramide. Proposed fragmentation pathways of F) deprotonated
metoclopramide in negative mode, and G) protonated metoclopramide in
positive mode.
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Table 2.4: Accurate masses of some DAPCI-MS/MS generated fragments of
deprotonated metoclopramide
Measured mass Molecular formula Error (ppm)
283.1078 C13H18ClN3O2 -3.5
211.0258 C9H8ClN2O2 -7.6
197.0160 C8H6ClN2O2 -6.1
156.0220 C7H7ClNO 2.6
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Table 2.5: Accurate masses of some DAPCI-MS/MS generated fragments of
protonated metoclopramide
Measured mass Molecular formula Error (ppm)
227.0592 C10H12ClN2O2 2.2
184.0159 C8H7ClNO2 -3.3
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Figure 2.4: Positive mode DESI-MS (A) and ND-EESI (B) spectra of
erythromycin, and proposed fragmentation pathways of protonated
erythromycin (C and D)68
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Erythromycin is a broad spectrum, macrolide antibiotic containing a lactone ring and
two sugar moieties: L-cladinose and D-desosamine. It is produced for commercial
use from a strain of actinomycete called Saccharopolyspora erythraea. Positive
mode mass spectra of erythromycin ionised by DESI and ND-EESI are shown in
Figure 2.4. The base peak in both spectra is [M+H]+, but significant amounts of
[M+Na]+ and [M+K]+ species are also present. Peaks at m/z 576.8 and 558.7 are
indicative of loss of D-desosamine and L-cladinose respectively. The ND-EESI
spectrum contains more species than the DESI spectrum, these may be due to
additional components or an increase in fragmentation of the erythromycin during
ND-EESI ionisation.
Nicotine from Tobacco
Nicotine is a naturally occurring alkaloid present in the tobacco plant. Dried tobacco
from a commercial cigarette was analysed by means of positive ion mode DAPCI,
DESI and DART. The mass spectra acquired are shown in Figure 2.5 A-C.
At a low cone voltage, a single ion at m/z 163 (corresponding to protonated nicotine)
was observed by DESI and DAPCI. The higher cone voltage used on the DART
source resulted in in-source fragmentation of the protonated nicotine species. The
fragmentation pattern observed by this method is very similar to that obtained by
DAPCI-MS/MS of m/z 163 (Figure 2.5 D). Elemental composition assignments for
observed product ions of protonated nicotine are listed in Table 2.6.
The protonated molecule fragments by the loss of 31 Da to form an ion at m/z 132.
Accurate mass measurement confirms this loss to be CH3NH2 from the methyl-
substituted pyrrolidine ring. The base peak in the spectrum, m/z 130, is formed by
loss of H2 from m/z 132. Other ions at m/z 117 and 106 are possibly formed from the
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m/z 132 species by the loss of a methyl radical and C2H2 molecule respectively. The
methyl radical loss has been reported previously (Byrd et al., 2005). Other easily
recognised product ions resulting from cleavage of the bond between the methyl-
substituted pyrrolidine ring and the pyridine ring are found at m/z 84 and 80
respectively.Figure 2.5: Positive ion mass spectra of tobacco ionised by: A) DAPCI, B)
DESI and C) DART. Positive ion accurate mass MS/MS spectrum (D) and
proposed positive ion fragmentation pathway (E) of protonated nicotine.70
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A proposed fragmentation scheme is shown in Figure 2.5 E, and is similar to the
scheme previously proposed (Byrd). Accurate mass MS/MS also supports this
hypothesis.
Table 2.6: Accurate masses of some DAPCI-MS/MS generated fragments of
protonated nicotine
Measured mass Molecular formula Error (ppm)
132.0820 C9H10N 5.3
130.0674 C9H8N 13.1
117.0596 C8H7N 15.4
106.0660 C7H8N 2.8
84.0828 C5H10N 17.8
80.0542 C5H6N 52.5
Proctosedyl ointment
Proctosedyl contains two active ingredients, cinchocaine hydrochloride (a topical
anaesthetic) and hydrocortisone (a corticosteroid hormone). Figure 2.6 shows the
mass spectra of proctosedyl ionised in positive mode by DESI, DAPCI and
solventless DAPCI. Protonated hydrocortisone (m/z 363) is present in all three
spectra, but the signal intensity when ionised by DESI and solventless DAPCI is
significantly lower than when analysed by means of DAPCI with solvent. The
cinchocaine hydrochloride protonates well (m/z 344) by all three methods.
Figure 2.7 shows a comparison of proctosedyl ointment ionised by DAPCI with
solvent, and DART. The DART ionisation method generates abundant protonated
cinchocaine hydrochloride species, but only a very weak hydrocortisone signal.
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Negative ion DAPCI and positive ion DAPCI spectra of proctosedyl are shown in
Figure 2.8 A and B. An intense signal for cinchocaine hydrochloride can be observed
in the negative mode spectrum (m/z 342), but hydrocortisone is absent.
A
a
i
s
F
pFigure 2.6: Positive ion mass spectra of proctosedyl ointment ionised by
DESI (top) DAPCI without solvent (middle) and DAPCI with solvent
The m/z 363 region in the DESI and DAPCI without solvent has been magnified
by a factor of 16 to show the low abundance hydrocortisone [M+H]+ species.72
ccurate mass MS/MS of protonated and deprotonated cinchocaine hydrochloride
re shown in Figure 2.8 C and D. Elemental compositions of some observed product
ons are presented in tables 2.7 and 2.8. The base peak in the [M-H]- MS/MS
pectrum at m/z 200 is formed by the loss of C7H14N2O from the molecular ion.
urther fragmentation of the m/z 200 species occurs to form the ion at m/z 144. The
roposed fragmentation pathway is shown in Figure 2.8 E and F.
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P
m
f
PFigure 2.7: A) Positive ion DART-MS spectrum, and B) positive ion DAPCI-
MS spectrum of proctosedyl ointment.73
ositive mode MS/MS of protonated cinchocaine hydrochloride yields a base peak at
/z 271. This ion is formed from the loss of C4H11N1 and can undergo further
ragmentation to m/z 251 by loss of C4H8 (supported by accurate mass measurement).
roposed fragmentation pathways for these two ions are shown in Figure 2.8 E and
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F, and probable elemental compositions for other ions in the MS/MS spectrum are
listed in tables 2.7 and 2.8.Figure 2.8: DAPCI-MS spectra of proctosedyl ointment in A) negative ion
mode and B) positive ion mode. Accurate mass MS/MS of C) deprotonated
cinchocaine hydrochloride in negative ion mode, and D) protonated
cinchocaine hydrochloride in positive ion mode. E) Proposed negative ion
fragmentation of [M-H]- and F) proposed positive ion fragmentation of
[M+H]+ of cinchocaine hydrochloride.
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Table 2.7: Accurate masses of some DAPCI-MS/MS generated fragments of
deprotonated cinchocaine hydrochloride
Measured mass Molecular formula Error (ppm)
200.1078 C13H14NO 1.5
144.0468 C9H6NO 13.2
Table 2.8: Accurate masses of some DAPCI-MS/MS generated fragments of
protonated cinchocaine hydrochloride
Measured mass Molecular formula Error (ppm)
271.1451 C16H19N2O2 1.5
215.0821 C12H11N2O2 0.0
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Detection of Ibuprofen Gel From Skin
Ibuprofen is a non-steroidal anti-inflammatory drug that acts as an antipyretic,
analgesic and anti-inflammatory.
A thin layer of ibuprofen gel was applied to the surface of a human finger. The gel
was gently massaged until absorbed. Negative ion DESI with a reduced desolvation
temperature (100 ºC) was used to detect the drug at the point of application.
Figure 2.9 shows the DESI-MS spectrum of ibuprofen 20 minutes after application to
the skin. The deprotonated ibuprofen (m/z 205) is the base peak in the spectrum.
Accurate mass MS/MS of the deprotonated ibuprofen species results in a single
fragment ion at m/z 161.1321, consistent with a proposed loss of CO2.
Figure 2.9: A)
from skin. B) NNegative ion DESI-MS spectrum of ibuprofen gel desorbed
egative ion DAPCI accurate mass MS/MS spectrum obtained
from deprotonated ibuprofen75
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Detection of ibuprofen metabolites from human urine
The development of a rapid screen for drugs and drug metabolites from urine is
simplified by the use of DESI and DAPCI. ESI-MS cannot be used in the direct
analysis of urine due to its inherent intolerance of salts. Time consuming desalting or
extraction of metabolites from whole urine must be performed before analysis by
ESI.
After ingestion, a number of modifications to ibuprofen are made, including:
hydroxylation, carboxylation and glucuronidation (Glowka and Karazniewicz, 2005).
A sample of human urine was obtained 60 minutes after oral administration of two
200 mg ibuprofen tablets. Negative ion mode DAPCI was used for the detection of
ibuprofen metabolites in the urine sample. Urine was spotted on to a piece of filter
paper before being introduced in to the DAPCI source.Figure 2.10: Negative ion DAPCI-MS spectrum of a urine sample taken 60
minutes after an oral dose of 400 mg of ibuprofen (A and B). C) Negative ion
DAPCI-MS/MS spectrum of m/z 221 (hydroxyl-ibuprofen).
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Figure 2.10A shows the negative ion mass spectrum obtained without any pre-
treatment of the urine sample. The sample contains a number of ions that may be
ascribed to endogenous components, including tentative assignments of
deprotonated: pyruvic acid (m/z 87), lactic acid (m/z 89), methylmalonic acid (m/z
117), xanthine (m/z 151) and hippuric acid (m/z 178).
The accurate mass spectrum obtained using deprotonated ibuprofen as a lock mass is
shown in Figure 2.10 B. Two species corresponding to deprotonated hydroxyl-
ibuprofen (m/z 221) and carboxy-ibuprofen (m/z 235) were detected. No glucuronide
metabolites were detected.
MS/MS of the deprotonated hydroxyl-ibuprofen resulted in a single product ion at
m/z 177 through the loss of CO2 shown in Figure 2.10C.
Conclusions
DART, DESI and DAPCI (with and without solvent) have been demonstrated as a
means of ionising a range of molecules of pharmaceutical interest, with little or no
sample pre-treatment. Significant differences between the ionisation approaches were
observed. Compounds of moderate to low polarity were more amenable to ionisation
by DAPCI (with and without solvent) than by DESI or DART.
The previously described approach of ASAP was found to be very similar to
solventless DAPCI.
DESI and DAPCI have been shown to provide a robust means of interrogating the
active ingredients in a variety of pharmaceutical formulations. Sampling is rapid and
ionisation occurs almost instantly. The orientation and positioning of the sample
surface in DESI and DAPCI seems to be more critical than with the DART source.
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The use of a Q-TOF I instrument with elevated resolution and full scan sensitivity
has improved selectivity and specificity of the DAPCI technique originally described
by Cooks and co-workers (Takáts et al., 2005). The high information content has
allowed probable elemental compositions and fragmentation pathways to be
proposed.
DESI was shown to be able to detect ibuprofen from the surface of skin with good
sensitivity. DAPCI has been demonstrated to be effective in the detection of
ibuprofen and its metabolites in urine after ingestion despite the high levels of
endogenous salts present.
Development of these new ionisation techniques offers significant advantages for a
number of analytical areas including rapid characterisation of pharmaceuticals, and
forensic detection of drugs and drug metabolites from skin and urine.
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Chapter 3:
Shape Selective Studies of Isomeric
Glucose Homopolymers
Chapter 3: Ion Mobility of Glucose Polymers
Glucose Homopolymers
Dextran and maltodextrin are two glucose homopolymers (poly-Glc) which differ in
chemical structure only by the glycosidic linkage type present.
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Figure 3.1: Molecular structures of A) dextran and B) maltodextrin82
extran
extran is a linear α 1-6 linked glucose polymer (Figure 3.1A) synthesised by the
acterium Leuconostoc mesenteroides. Dextran has a wide range of clinical
pplications including the use of 40-70 kDa solutions as emergency blood
eplacement, and plasma substitution. Lower molecular weight dextrans are
ombined with iron to form a complex which is highly efficient at delivering iron to
atients with anaemic iron deficiency. Dextran can also be used as a molecular
eight calibrant in mass spectrometry due to the well defined molecular weight
istribution of commercially available samples.
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Maltodextrin
Maltodextrin is an α 1-4 linked glucose polymer (Figure 3.1B) derived from the
hydrolysis of starch. Maltodextrin is predominantly used in the food industry as a
thickening agent. It is easily digested to glucose in the body.
Both dextran and maltodextrin have the ability to form complexes with metal ions
and their regular structures make them suitable model systems for studying
carbohydrate-based shape selective interactions with cations.
Previous Studies of Poly-Glc Structures
Previous studies on dextran and maltodextrin have been carried out using a range of
analytical techniques and modelling approaches.
Results from X-ray diffraction (Bluhm and Zugenmaier, 1981) and nuclear magnetic
resonance (NMR) (Brant et al., 1995) measurements have indicated that maltodextrin
in crystalline form, or in solution, maintains a structured and more compact helical
conformation than dextran oligomers of equivalent length. The absence of a similar
structure in the dextran chain is thought to be due to the much greater conformational
freedom associated with the α 1-6 glycosidic bond (Tvaroska and Kozár, 1981).
Investigations of cation binding affinities and resultant ionisation efficiencies of
linear and cyclic poly-Glc by MALDI-MS have been carried out by multiple groups
(Bashir et al., 2003; Choi et al., 2009). Alkali metal ions: Li+, Na+, K+, Rb+, Cs+ have
been demonstrated to coordinate to carbohydrate polymers with varying binding
affinities.
Further work by Bashir et al. (Bashir et al., 2004) investigated the fragmentation of
poly-Glc oligomers during analysis by MALDI-MS/MS. CID experiments on
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poly-Glc oligomers resulted in abundant glycosidic bond cleavages and some
pyranose ring cleavage of dextran. It was also reported that the degree of
fragmentation of poly-Glc compounds during MALDI in-source decay fragmentation
experiments is related to the stability of their solution phase structure (as obtained
through NMR studies by (Vetter and Thorn, 1992)). Polymers with more constrained
conformations or defined secondary structures (e.g. maltodextrin and cyclodextrins)
yielded fewer fragment ions than those with ill-defined secondary structure.
Ion mobility mass spectrometry has been utilised in the study of cation attachment to
a number of oligomeric systems including polystyrene (Gidden et al., 2000),
polyethylene glycol and polypropylene glycol (Gidden et al., 2002). These studies
indicate that different oligomeric systems can incorporate varying cation binding
mechanisms and that cation type can influence the number of atoms that are involved
with cation interation. In these studies no systematic attempt was made to investigate
the effect of oligomer number on cation binding.
Objectives
The aim of this study was to investigate the conformational changes that occur when
a range of cations are bound to oligomeric carbohydrate systems. Two closely related
carbohydrate systems were employed and a wide range of selected cation species
studied.
The Synapt HDMS ion mobility instrument was used to probe conformational
variation with: carbohydrate isomer, oligomer length (molecular weight) and cation
used for sample ionisation.
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Estimated cross sections of ion mobility-resolved, arrival time distributions for
poly-Glc oligomers complexed with alkali metal cations were calculated to provide
instrument-independent values for comparison of mobility separated species.
Materials
Dextran 5000 was purchased from Fluka (Dorset, U.K.). Maltodextrin, metal salts
(lithium chloride, sodium chloride, potassium chloride, rubidium chloride and
caesium iodide), proteins (serum albumin (bovine), cytochrome C (equine), aldolase
(rabbit), transferrin (human), myoglobin (equine), creatine phosphokinase (rabbit),
haemoglobin (rabbit) and trypsin) and Nafion-117 membrane were obtained from
Sigma-Aldrich (Dorset, U.K.). Hydrochloric acid was obtained from Fisher Scientific
(Loughborough, U.K.). Methanol and water were of LC/MS grade purchased from
Mallinckrodt Baker (U.S.A). Borosillicate glass nano-flow capillaries were
purchased from Waters (Waters, Manchester, U.K.).
Experimental
Cation Attachment
To ensure that the selected cation was dominant in the experiments, a cation
exchange membrane, Nafion-117, was used to form complexes between the cation of
interest and the poly-Glc sample (Börnsen et al., 1995).
Nafion-117 membrane was prepared for cation exchange by incubation in
concentrated hydrochloric acid at 95 ºC for two hours. The membrane was then
washed with distilled water to remove any remaining acid. A piece of Nafion
membrane was floated on the surface of 0.1 M HCl solution (for sample protonation)
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or 0.1 M alkali metal salt solution (LiCl, NaCl, KCl, RbCl, CsI for respective sample
cationisation).
Poly-Glc samples were dissolved in water to a concentration of 2 mg mL-1. 10 µL
aliquots were spotted on to the surface of the prepared Nafion-117 membrane. After
30 minutes, samples were removed from the membrane surface, mixed in a 1:1 ratio
with methanol, and placed in to a nano-flow capillary for analysis.
TWIM-MS Analysis
TWIM-MS analysis was performed in a hybrid quadrupole/ion mobility/orthogonal
acceleration time-of-flight mass spectrometer (Synapt HDMS, Waters, Manchester,
U.K.) operated in positive ion electrospray mode. Samples were infused by means of
borosilicate glass nano-flow capillaries typically at a flow rate of 100 – 200 nL min-1.
The source temperature was 120 ºC, the capillary voltage was operated at 1.2 kV,
and the cone voltage was kept at 50 V throughout all experiments. The gas in the
TriWave IMS region was nitrogen, operated at flow rates from 24 - 42 mL min-1
(4.55 - 7.61 × 10-1 mbar respectively). The T-Wave height was fixed at either 8 or
12 V whilst the IMS gas cell pressure was optimised. During the wave height
optimisation, the IMS gas cell flow was maintained at 30 mL min-1. The T-Wave
velocity was fixed for all experiments at 300 m sec–1. The m/z acquisition range was
from 100 to 3000 and mass spectra were obtained at a rate of 1 spectrum s-1. Ion
mobility separation experiments take place in 18 ms and are divided in to 200 time
bins of 90 µs. Each time bin contains mass spectral information for all ions detected
in that period.
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Ion mobility separation conditions were optimised using the [dextran + nCs]n+
sample to achieve an ion mobility separation of ions, while ensuring all ions had left
the IMS TWIG before the next gated release of ions from the trap TWIG.
Cross Section Calibration and Estimation
The cross section calibration method used (Thalassinos et al., 2009) is a modified
version of that proposed by Wildgoose et al. (Wildgoose et al., 2006). Calibrant
molecules of known cross section are analysed on the Synapt HDMS under the same
experimental conditions as the unknown samples under investigation. The time bin
(scan number) in which the calibrant arrives is converted to an arrival time by
multiplying by the oa-TOF pusher period. This arrival time is corrected for mass
dependent and mass independent flight time (t(d)’’). The mass independent time is
the time taken to traverse the IMS and transfer TWIGs and does not depend on m/z.
The mass dependent time is the time from the ion leaving the transfer TWIG to it
arriving at the detector. This time is proportional to the square root of the m/z of the
ion. The published cross sections for the calibrant ions are scaled by taking in to
account the reduced mass and charge state of the ion (’). A plot of t(d)’’ versus ’
is made, and a curve fitted to the data. Typically a power series curve is appropriate
for proteins, and a linear series for peptides. The equation of this line, together with
the t(d)’’ of the unknown samples are used to calculate estimated cross sections. A
suitable calibrant for cross section estimation should bracket the mobilities of the
unknown samples, not their cross sections (Shvartsburg and Smith, 2008).
The calibration compounds used were doubly sodiated dextran oligomers, and
doubly protonated peptides from a number of proteins (serum albumin (bovine),
cytochrome C (equine), aldolase (rabbit), transferrin (human), myoglobin (equine),
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creatine phosphokinase (rabbit), haemoglobin (rabbit)) digested with trypsin. Cross
sections for doubly protonated tryptic peptides have been obtained from a published
database (Valentine et al., 1999). Cross sections for doubly charged dextran
oligomers were measured by means of DCIM-MS by collaborators at the Univeristy
of California, Santa Barbara (UCSB). DCIM-MS was not been used for measurement
of all other poly-Glc cross sections due to considerations of speed, sensitivity and
ease of use of instrumentation.
Results and Discussion
Product Ion Mass Spectra
Figure 3.2 shows the product ion spectra produced from the sodium attachment ions
of the tetramers m/z 689, [M+Na]+ of maltodextrin and dextran. Using the Domon
and Costello nomenclature(Domon and Costello, 1988) carbohydrates are labelled A,
B, C from the non-reducing end and X, Y, Z from the reducing end. Since the
samples studied here are homopolymers we are unable to assign uniquely the identity
of the ring involved. A and X ions are produced by cleavage across the glycosidic
ring and are labelled by assigning each bond a number and counting clockwise. As
may be expected from the isomeric nature of the two compounds, the major fragment
ions, at m/z 527, 365 and 203 are common. These fragments are formed from the
cleavage of the inter-ring glycosidic bonds and indicate a repeat unit of m/z 162. The
peaks at m/z 629, 569, 467, 407 and 305 are again common to both spectra and are
formed by intra-ring cross cleavage. Using the above nomenclature these may be
labelled 0,4X4, 0,2X4, 0,4X3, 0,2X3, 0,4X2 and 0,2X2 respectively. The peaks at m/z 671,
509, 347 and 185 are formed by water loss with glycosidic ring cleavage and are
again seen in both spectra. Under the conditions of the MS/MS experiment there are
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a series of ions which are present in the dextran product ion spectrum but are either
very weak, or absent, in the maltodextrin product ion spectrum. The ions are found at
m/z 599, 437, and 275. These ions also correspond to intra-ring cross cleavage
fragmentations and can de designated 0,3X4, 0,3X3 and 0,3X2 respectively. These ions
presumably reflect the three dimensional structural variation of the two oligomers
and enable them to be differentiated at the single molecule level. It is not possible
however to utilise this information to comment on the details of the differences.
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Figure 3.2: Tandem MS spectra of tetramers of sodiated maltodextrin (top)
and dextran (bottom)89
ross Section Calibration
wo cross section calibrations have been produced, one using [dextran + 2Na]2+
ligomers, and the other using doubly protonated tryptic peptides. The dextran t(d)’’
ersus ’ plot was fitted with a power series trend line for use in cross section
stimation (Figure 3.3). For the plot of t(d)’’ versus ’ for the tryptic peptides
Figure 3.4) a linear trend line was more appropriate.
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sections for 19 tryptic peptides
ryptic peptides from serum albumin (bovine), cytochrome C (equine), aldolase
rabbit), transferrin (human), myoglobin (equine), creatine phosphokinase
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for 19 tryptic peptides estimated using a peptide based calibration
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To verify the accuracies of the two calibrations, a plot of published absolute cross
sections and estimated cross sections calculated using each of the dextran and
peptide based calibrations have been made (Figures 5-6). A perfect calibration will
yield a linear trend line with a correlation co-efficient of 1.0. Although both gave
good calibrations, the dextran based cross section calibration was observed to have a
marginally better correlation, and was based on the compound type to be studied and
has therefore been used for the cross section calculations presented here.
Cation Attachment
Dextran and maltodextrin were both successfully cationised with all cations
investigated (H, Li, Na, K, Rb, Cs). Singly, doubly and triply cationised species were
observed covering a wide mass range (500 – 6000 Da). No significant differences
were observed between the individually averaged ESI mass spectra of the dextran
and maltodextrin samples demonstrating that, due to the isomeric nature of the
systems, these samples cannot be differentiated using simple mass spectra alone. A
small difference in relative abundances of some charge states was observed between
the dextran and maltodextrin, but this may be due to differences in the molecular
weight distribution of the samples. The polydispersity of the samples precluded
measurement of the average molecular weight directly using MALDI mass
spectrometry. This value could have been obtained via fractionation of the samples
followed by analysis of the individual narrow molecular weight distributions
(Montaudo and Lattimer, 2001).
TWIMS-MS Separation and Cross Section Estimation
Ion mobility separations were achieved for all observed cationised dextran and
maltodextrin oligomers. Extracted ATD data for mobility separated poly-Glc
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oligomers has been used to calculate estimated cross sections for a range of
cationised species.
Figures 3.7– 3.12 show plots of estimated cross sections of dextran and maltodextrin
ionised with each cation type. m/z values for poly-Glc species have been converted to
oligomer length to allow comparisons of species independent of cation mass.Figure 3.7: Estimated cross sections for dextran and maltodextrin oligomers
cationised with H+
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Chapter 3: Ion Mobility of Glucose PolymersFigure 3.9: Estimated cross sections for dextran and maltodextrin oligomers
cationised with Na+
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Chapter 3: Ion Mobility of Glucose PolymersFigure 3.11: Estimated cross sections for dextran and maltodextrin
oligomers cationised with Rb+
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rom these measurements a number of interesting observations may be made.
or all singly cationised species, which cover a relatively narrow oligomer range of
3-6] there is no observable difference between dextran and maltodextrin within the
alibrated cross section range. This indicates that cation size and presumably mode
f interaction, are not dominant features over this narrow oligomeric range.
or doubly cationised species, which cover the rather larger oligomeric range of [9-
2], maltodextrin estimated cross sections are lower than those calculated for
extran. This measured difference in cross section increases with increasing oligomer
ength.
or triply cationised species, which overlap the doubly charged region and cover the
ligomer range [19-35], maltodextrin estimated cross sections are consistently lower
han those calculated for dextran. The differences in cross section are larger than
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those observed in the doubly charged region, and increase with increasing oligomer
length.
For species where both doubly and triply charged oligomers are observed, the triply
charged species have a lower observed cross section than those observed for the
equivalent doubly charged species.
These results indicate, as expected, that the ability of the carbohydrate chain to
coordinate with more than one cation increases with oligomer length. The fact that
the triply cationised species has a smaller cross-section than that of the doubly
charged species can be explained by the need for more atoms to be coordinated.
Variation of Cross Section with Attached Cation
Figures 3.13 – 3.18 show estimated cross sections of dextran and maltodextrin
oligomers at individual charge states with each cation. These results show clearly
that the estimated cross sections observed for a selected oligomer and charge state do
not vary with the nature of cation bound, over the calibrated range, within the
expected variation of the experiment which has previously been estimated at (2-3%)
(Scarff et al., 2008). A small difference is observed at higher oligomer numbers as
seen in Figures 3.15 and Figure 3.18 where the triply caesiated species have a larger
estimated cross-section due, presumably, to the coordination requirements of the
larger cation.
Chapter 3: Ion Mobility of Glucose PolymersFigure 3.14: Estimated cross sections for all doubly cationised dextran
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Chapter 3: Ion Mobility of Glucose PolymersFigure 3.16: Estimated cross sections for all singly cationised maltodextrin
oligomers
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Chapter 3: Ion Mobility of Glucose PolymersFigure 3.18: Estimated cross sections for all triply cationised maltodextrin
oligomers
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Conclusions
The use of Nafion-117 membrane enables the selective cationisation of
carbohydrates for study by mass spectrometry. Multiple cationisation enables a wide
range of molecular weight species to be studied. In this experiment, singly, doubly
and triply charged species, covering a mass range of 500 – 6000 Da have been
observed.
The T-Wave ion mobility based Synapt instrument enables the rapid and sensitive
shape selective separation of complex carbohydrate mixtures. When calibrated with
molecules of known cross section, estimated cross sections can be calculated from
the arrival time data recorded for each ion in the mass spectrum.
Long linear carbohydrates can provide multiple sites for cation attachment. The
cation bound to these poly-Glc structures does not cause a significant change in
rotationally averaged cross section.
Estimated cross sections for dextran and maltodextrin were observed to be in
agreement with trends proposed from solution phase NMR structures (Brant et al.,
1995), with maltodextrin (where measurable differences were seen) having
consistently smaller cross sections than the equivalent dextran oligomers. This
supports the view that gaseous structures, studied using ion mobility mass
spectrometry experiments of the type employed here, maintain important features of
their solution behaviour.
TWIM-MS provides a rapid, sensitive and shape selective technique for the analysis
of isomeric carbohydrates. This approach enables a number of important questions
regarding the nature of interaction of the oligomeric chains with cations to be probed.
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The fact that the nature of the coordinating cation has such a small effect on
estimated cross section indicates that the dominant conformation is driven by the
carbohydrate structure itself. The relative size at which multiple cation binding takes
place is also related to the cation attachment process. The ability of the approach to
measure relatively small differences in the gaseous conformation of isomeric
carbohydrate oligomers gives confidence in the selectivity of the technique. The
relatively large molecular weight range of oligomeric species that can be studied in
one experiment (500-6000 Da) enables molecular weight dependant features to be
readily studied. The speed, selectivity and information content of the mobility
experiments that can be carried out on the commercial instrument mean that
comprehensive, detailed studies of complex systems can be undertaken for the first
time giving access to data that was not previously accessible in a reasonable
timescale.
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Introduction
Characterisation of Glycosylation
Glycosylation is the co- and post-translational attachment of carbohydrate structures
to a protein backbone. The carbohydrate moieties of these glycoconjugates have
many important roles in biological systems. These roles include protein folding,
cell-cell recognition and protection from proteolysis (Dwek, 1996). Glycosylation is
one of the most prevalent forms of covalent protein modification, occurring for
approximately 50% of all proteins in eukaryotic systems. Mammalian and plant
glycoproteins can be either N-linked or O-linked. In N-linked glycosylation,
oligosaccharides bind to the amide nitrogen of asparagine side chains. In O-linked
glycosylation, they bind to the hydroxy oxygen of serine and threonine side chains.
Addition of carbohydrate-containing GPI anchors to proteins to allow for membrane
attachment can also be considered a special form of glycosylation.
Despite the importance of oligosaccharides in biological systems, structural
determination of these molecules is an analytical challenge compared to other
biomolecules. Not only do the constituent monosaccharides (and their
stereochemistry) have to be identified, but how they link together to form the
polymer needs to be determined. Given that monosaccharides have multiple linkage
sites and each site has two possible anomeric linkage configurations, oligosaccharide
structure can be very complex (Harvey, 2001). Mass spectrometry (MS) has proven
to be a valuable tool in the study of oligosaccharides. With the help of chemical
degradation, derivatisation and mass spectral fragmentation, oligosaccharide
structure can be elucidated. There are also practical motivations for advancing
glycomic research. For example, the pharmaceutical industry makes increasing use
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of recombinant synthesis of proteins due to the reduced cost and increased quality
over extraction and purification approaches (Ma et al., 2003). Modern methods can
incorporate post-translational modifications such as phosphorylation and
glycosylation and there is a requirement for a rapid, sensitive, information-rich
method to monitor glycosylation in these systems for process optimization and
quality control purposes.
Ion mobility-mass spectrometry
Conventional mass spectrometry only takes advantage of mass separation and gives
no direct information about three-dimensional shape. Ion mobility-mass
spectrometry (IMMS) uses not only traditional mass separation techniques, but also
separates ions based on their mobility in an inert buffer gas. The method can,
therefore, distinguish isomers with identical masses but different cross sections. In
traditional IMMS, a weak uniform electric field is applied across a mobility cell
(using direct current) to pull ions through a helium buffer gas. Compact isomers
with higher mobilities exit the cell before more extended isomers that have lower
mobilities. This direct-current ion mobility spectrometry (DCIMS) configuration
allows for the measurement of a well-defined ion mobility and thus, using kinetic
theory, determination of an ion’s collision cross section. Comparing experimental
cross sections to those of theoretical structures reveals information about the true
gas-phase structures being observed experimentally. In the Bowers group, this
method has been applied successfully to a number of biological systems, including
DNA helices (Gidden et al., 2004; Gidden et al., 2005), G-quadruplexes (Baker et
al., 2005; Baker et al., 2006; Gabelica et al., 2007) and the Alzheimer’s peptides
Aβ40 and Aβ42 (Bernstein et al., 2005; Baumketner et al., 2006). Despite the fact
that these biomolecules have undergone electrospray ionization (ESI) for transfer to
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the gas phase, evidence suggests that to a significant extent, solution-phase
conformations are retained. This characteristic has also been observed by other mass
spectrometry groups. Pioneering work by Robinson (Last and Robinson, 1999)
demonstrated “compelling evidence for preservation of tertiary structure under
controlled conditions” and a review by Heck (Heck and van den Heuvel, 2004),
describing the analysis of intact protein complexes by mass spectrometry, strongly
supports this view.
The development of travelling wave ion mobility spectrometry (TWIMS) (Giles et
al., 2004) has significantly increased sensitivity and speed in comparison with the
traditional DCIMS device, allowing for the analysis of samples at biologically-
relevant concentrations. TWIMS has been integrated into a commercial quadrupole
time-of-flight instrument, the Synapt HDMS System (Waters, UK).(Pringle et al.,
2007) The Synapt operates with excellent reproducibility and mass accuracy, and is
capable of providing a wealth of information being able to achieve ion mobility
spectrometry-tandem mass spectrometry (IMS-MS/MS) with the choice of
performing collision-induced dissociation before or after the mobility cell. The
nature of the TWIMS device means that, unlike in DCIMS, the ion drift time is not
inversely proportional to ion mobility and thus absolute collision cross sections
cannot be obtained directly from drift cell information. It has been shown, however,
that estimates of collision cross sections can be obtained by reference to samples
with known cross sections (Ruotolo et al., 2005; Scarff et al., 2008; Williams and
Scrivens, 2008; Thalassinos et al., 2009), provided that the data is obtained under the
same experimental conditions; i.e. mobility gas, gas pressure, wave velocity, wave
height, pusher frequency and injection energy.
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Ion mobility based analysis of oligosaccharides
Ion mobility methods have previously been used to study oligosaccharides. DCIMS
investigations have been used to obtain structures of several small sodiated sugars
(Lee et al., 1997; Jin et al., 2005) and to demonstrate the separation capability for a
number of carbohydrate isomers (Liu and Clemmer, 1997; Lee et al., 1998; Clowers
et al., 2005). Clemmer and co-workers have lately used traditional DCIM-MS to
examine glycans released from ovalbumin (Plasencia et al., 2008). Recent work
from the group of Hill (Dwivedi et al., 2007) expands on previous research by
describing the successful resolution of carbohydrate isomers with different anomeric
configurations together with the use of adducts and variation of mobility gas to
improve separation. Differential mobility spectrometry has been employed to study
aggregate formation in the analysis of oligosaccharides (Levin et al., 2007). This
work describes the results of a combined DCIMS and TWIMS investigation of a
range of oligosaccharides. The ability of the TWIMS method, coupled with MS and
MS/MS approaches, to characterize carbohydrates released from a number of
glycoproteins (Table 4.1) is explored. The structures of the carbohydrate moieties
associated with each of these proteins have been previously studied by methods such
as NMR and traditional mass spectrometry (Yoshima et al., 1981; Green et al., 1988;
de Waard et al., 1991; Fu et al., 1994; Da Silva et al., 1995; Harvey et al., 2000).
With standard analysis methods, structural characterization can only occur after some
sort of chromatographic separation technique, such as HPLC, has been applied.
Chapter 4: Ion Mobility of Glycans
111
Objectives
The sensitivity of the TWIM-MS technique, together with the rapid experimental
timescale, reproducibility and high information content make this an attractive
approach for the characterization of complex mixtures in glycomic research.
The following experiments aimed to rapidly separate N-glycans released from
glycoproteins based on their ion mobility in TWIM-MS. Glycans released from a
number of glycoproteins have been analysed by TWIM-MS, and it has been observed
that the carbohydrates are readily separated by this method.
A series of isomeric penta- and hexasaccharides have also been examined (Table 4.1)
using both the DCIMS and TWIMS techniques to evaluate the isomer separation
capabilities of the two methods. In the DCIMS experiments, collision cross sections
for the sodiated oligosaccharides were obtained. By comparing these values with
cross sections of model structures acquired by molecular mechanics calculations, it
has been possible to determine potential gas-phase structures of these species. In
addition, the DCIMS experimental cross sections are compared to the TWIMS
results. Carbohydrates (glycans) released from the glycoproteins are readily
separated by ion mobility in TWIM-MS. Common glycans (e.g. Man5-7GlcNAc2,
where Man = mannose, GlcNAc = N-acetylglucosamine) were observed to have the
same arrival time distribution independent of their source. This indicates that,
despite the presence of other species in a complex mixture, arrival time
measurements are reproducible. Tandem mass spectrometry experiments on
components separated using ion mobility are also demonstrated and found to provide
additional information regarding carbohydrate structure.
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Table 4.1. Glycans Investigated in this Study
TWIMS-MS: Glycans released from the following glycoproteins
bovine ribonuclease B
chicken ovalbumin
porcine thyroglobulin, desialylated porcine thyroglobulin
bovine fetuin, desialylated bovine fetuin
human α1-acid glycoprotein, desialylated human α1-acid glycoprotein
DCIMS- and TWIMS-MS: Penta- and Hexasaccharides
Name Structure
(abbreviation)
B-pentasaccharide
(B-PS)
iso-B-pentasaccharide
(iso-B-PS)
lacto-N-fucopentaose I
(LNFP I)
lacto-N-fucopentaose V
(LNFP V)
lacto-N-difucohexaose I
(LNDFH I)
lacto-N-difucohexaose II
(LNDFH II)
Galα1 3Galβ1 4Glc
Fucα1
2 3
Fucα1
Galα1 3Galβ1 3Glc
Fucα1
2 4
Fucα1
Fucα1
2
Galβ1 3GlcNAcβ1 4Glc3Galβ1
Fucα1
3
Galβ1 3GlcNAcβ1 4Glc3Galβ1
Fucα1
2 4
Fucα1
Galβ1 3GlcNAcβ1 4Glc3Galβ1
Fucα1
34
Fucα1
Galβ1 3GlcNAcβ1 4Glc3Galβ1
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Experimental
Ion mobility spectrometry-mass spectrometry (IMS-MS)
DCIM-MS
All DCIM-MS based experiments were performed by collaborators in the Bowers
group at UCSB.
IMS-MS experiments at UCSB were performed on a home-built spectrometer
consisting of a nano-ESI source, an ion funnel, and a mobility drift cell followed by a
quadrupole mass analyzer and detector (Wyttenbach et al., 2001). Samples were
introduced into the nano-ESI source by means of a metal coated borosilicate
capillary (Proxeon, Odense, Denmark). The ions generated are transferred, via a
metal capillary, to the ion funnel where they can be accumulated and pulsed into the
drift cell. A weak uniform electric field is applied across the drift cell (using direct
current) to pull ions through a helium buffer gas (at ~1-5 mbar). To measure arrival
time distributions (ATDs), ions are pulsed from the funnel into the drift cell. Ions are
separated by their mobility, with compact structures travelling faster than extended
structures. Ions exit the drift cell and are mass analysed and detected as a function of
arrival time, tA. To measure mobility (K0), tA for a particular ion is measured as a
function of the drift voltage (V) applied to the cell (of known pressure (p) and length
(  )). As shown in eq 1, a plot of tA versus p/V yields a straight line with a slope
inversely proportional to K0 and has a y-intercept equal to t0, the amount of time the
ions spend outside the cell.

2
0
A 0
0 0
T pt = + t
K p T V
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4. 1
In this equation, standard temperature (T0 = 273.15 K) and pressure (p0 = 1.013 bar)
are used to obtain a mobility independent of cell temperature and pressure, i.e., the
reduced mobility, K0.
The mobilities obtained in this experiment can be used to calculate an ion’s collision
cross section using the following relationship obtained from kinetic theory (Mason
and McDaniel, 1988).
 
 
 



1/2
0
3ze 2 1=
16N kT K
4. 2
Here, z is the number of charges on the ion, e is the electronic charge, N is the buffer
gas number density, µ is the reduced mass of the ion and buffer gas, k is the
Boltzmann constant and T is temperature.
TWIM-MS instrument
All TWIM-MS experiments were performed in a hybrid quadrupole-ion mobility-
orthogonal acceleration time-of-flight (oa-TOF) mass spectrometer (Synapt HDMS,
Waters, Manchester, UK) at the University of Warwick. The instrument was
equipped with a nano-ESI source and operated at a source temperature of 120 ºC.
The sample solutions were introduced into the source region of the instrument by
means of metal coated borosilicate capillaries (Waters Corporation, Manchester,
UK). The cone was optimized between 60 and 130 V for ESI-MS/MS experiments
and the collision energy was optimized to fragment the ion of interest, typically 110
eV in positive and 70 eV for negative ESI mode. A detailed explanation of the
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Synapt HDMS technology can be found in chapter 1.5.2.1. Briefly: the machine is
comprised of three travelling wave enabled stacked ion guides: trap, ion mobility
separator and transfer. The trap ion guide is used to accumulate ions and releases
these as ion packets into the ion mobility separator for mobility separation. The
transfer ion guide is used to convey the mobility-separated ions to the oa-TOF mass
analyzer. Ions were mass selected using the quadrupole prior to MS/MS
experiments. All MS/MS experiments were performed after ion mobility separation
in the transfer cell. Optimised TWIM-MS operating conditions are listed in Table
4.2. The TOF analyzer recorded 200 orthogonal acceleration pushes (mass spectra)
with the pusher period set to an appropriate value depending on m/z acquisition
range. The total acquisition time for the data shown was combined and averaged
over 2 minutes. The TOF analyser was tuned in V-optic mode for an operating
resolution of 7,000 (FWHM). Mass spectra were acquired at an acquisition rate of
one spectrum per second with an interscan delay of 100 ms. Data acquisition and
processing were carried out using MassLynx™ (v4.1) software (Waters Corp.,
Milford, MA, USA).
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Table 4.2. Optimised TWIMS Cell Parameters
Sample ESI Mode Cell Gas
Pressure
T-Wave
Height
T-Wave
Velocity
Released N-
Glycans
Positive 0.5 11 400
Released N-
Glycans
Negative 0.5 18 500
Isomeric
Carbohydrates
Positive 0.75 14 300
Materials
Bovine ribonuclease B, chicken ovalbumin, porcine thyroglobulin, bovine fetuin and
human α1-acid glycoprotein were purchased from Sigma Chemical Co. Ltd. (Poole,
Dorset, UK). Ribonuclease B (Fu et al., 1994) and chicken ovalbumin (Da Silva et
al., 1995; Harvey et al., 2000) contain only neutral sugars. Thyroglobulin (de Waard
et al., 1991), fetuin (Green et al., 1988) and human α1-acid glycoprotein (Yoshima et
al., 1981) contained both sialylated and neutral sugars. Desialylated versions of
thyroglobulin, fetuin and α1-acid glycoprotein were generated using 10% acetic acid
for 30 min at 80 °C. The glycans from these proteins were released with hydrazine
(Patel et al., 1993) and dissolved in a mixture of H2O/methanol (1:1; v/v) to a
concentration between 10-25 pmol µL-1 for analysis using the Synapt instrument.
The six oligosaccharides B-pentasaccharide, iso-B-pentasaccharide, lacto-N-
fucopentaose I and V, and lacto-N-difucohexaose I and II were purchased from
Sigma-Aldrich Company Ltd. (Poole, UK) and were dissolved in a mixture of
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H2O/methanol (1:1; v/v) to a concentration of 10 pmol µL-1 for analysis using both
the DCIMS-MS and Synapt instruments.
Molecular modelling
Molecular modelling studies were performed by collaborators in the Bowers group at
UCSB.
Theoretical modelling of the six oligosaccharides investigated with DCIMS-MS was
done with the AMBER 8 package of molecular dynamics software (Case et al., 2004)
using the general AMBER force field. Using structures of the oligosaccharides built
in Hyperchem (2002), partial charges were calculated following the RESP procedure
within AMBER with Gaussian 03 (Frisch et al., 2004) and the 6-31G* basis set. A
set of initial structures was created for each oligosaccharide by building the molecule
in xleap, then varying the position of the sodium counter ion. A simulated annealing
protocol was used to generate 150-200 low-energy candidate structures for each
initial structure of the oligosaccharides. In this protocol an initial structure was
subjected to 30 ps of molecular dynamics at 600 K followed by 10 ps of dynamics
during which the temperature was lowered to 0 K. The resulting structure was then
energy minimized, saved, and used as the starting structure for the next cycle. The
collision cross sections of these candidate structures were then calculated using the
exact hard-sphere scattering and trajectory models developed by the Jarrold group
(Mesleh et al., 1996). For each oligosaccharide the average cross sections of the
lowest energy families of structures, which for the systems considered in this work
showed only minor structural deviations, were reported. Figures were prepared using
the UCSF Chimera package. (Pettersen et al., 2004)
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Results and Discussion
The rapid separation of chemically released N-linked glycans
The TWIM-MS-based approach offers a number of advantages for the analysis of a
complex mixture of released glycans. These include high sensitivity, rapid analysis,
no requirement for further sample preparation and the extremely high information
content of the experiment. In addition to mobility separation, mass spectral
information (both MS and MS/MS) can be obtained. By using an established
calibration approach, based on accepted rotationally averaged cross sectional values
obtained from conventional DCIMS experiments, estimated cross sections can also
be obtained. An attractive feature of IMMS is the millisecond timescale of ion
separation in the gas phase. This dovetails well with the second timescale of liquid
chromatography and the microsecond timescale of mass spectrometry data
acquisition. The established technique for separating oligosaccharide mixtures is
normal-phase high-performance liquid chromatography (HPLC) (Guile et al., 1996).
The IMMS approach can be used in a similar manner to HPLC for the rapid
separation of these complex mixtures without prior HPLC separation. To this end,
we have used the TWIM-MS and TWIM-MS/MS methods to investigate the N-
linked glycans released from the set of well-studied glycoproteins listed in Table 4.1.
Reproducibility of Ion Mobility Separations
The bovine ribonuclease B system will serve as a representative example of the type
of results we are able to achieve with our techniques. This protein is known to have
one glycosylation site that releases a mixture of oligosaccharides with the formulae
MannGlcNAc2, n = 5-9. The glycan structures have been determined by NMR
analysis (Fu et al., 1994). The ESI mass spectrum of these oligosaccharides (Figure
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4.1) is dominated by sodiated glycan species, which is consistent with previously
published spectra (Harvey, 2000).
A typical set of ATDs for one of the sodiated glycans, Man5GlcNAc2, is shown in
Figure 4.2. Each panel in the figure consists of 200 scans of 80 µs duration, giving a
total time for the experiment of 16 ms. In the first panel the ATD is centred on scan
91 giving an arrival time of 7.28 ms (91 × 80 µs). The other four panels, at intervals
of 200 scans, also peak at the ninety-first scan in the panel, demonstrating the
reproducibility of the method. Reproducibility of peak arrival time within one scan
(± 80 µs) is a typical result for the instrument. Subsequent ATDs shown in this paper
will be presented with the x-axis converted from scan number to arrival time.
Figure 4.1: Glycans released from ribonuclease B
Peaks are labelled with the corresponding unsodiated structure. The different linkages are
distinguished by solid and dotted vertical, horizontal and diagonal lines.
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on Mobility Separation of Glycans
igure 4.3 shows the ATDs measured for the four largest sodiated glycan peaks in
he ribonuclease B mass spectrum (MannGlcNAc2, n = 5-8). The distributions
epresent a typical glycan separation for this instrument which can be achieved in
16 ms. Each distribution is dominated by a single large peak that shifts to longer
rrival times as n increases. This is an expected result, given that the increased size
f an ion decreases its mobility as it passes through the mobility cell. For n = 5-7,
he ATD peaks broaden slightly as n increases. Again, this is expected since the
ore time ions spend travelling through the mobility cell, the larger the spread in
heir cell transit times becomes. The ATD peak for n = 8 is even broader than would
e expected based on the trend for n = 5-7. This additional broadening could be due
o the presence of Man8GlcNAc2 isomers.
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u et al. (Fu et al., 1994) indicates that both Man7GlcNAc2 and
d from ribonuclease B have three linkage isomers (as depicted
. It is not clear why the n = 7 ATD peak is not broader like the
7GlcNAc2 also has three isomers. It may be that cross sections
appen to be different enough to give a broader ATD, while it is
= 7 isomers. The presence of conformers may also play a role,
e n = 7 and 8 species resulting in a wider range of conformer
larger glycan.
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Charge state separation of multiply charged multimers
Each ATD in Figure 4.3 also has a small peak at shorter arrival times, for example, at
6.00 ms for n = 7 and 6.88 ms for n = 8, which are due to glycan dimers of the form
[2M + 2Na]2+. This type of behaviour has been observed before for the Alzheimer’s
peptides Aβ40 and Aβ42, where oligomers with the same m/z values as the monomer
have shorter arrival times (Bernstein et al., 2005; Baumketner et al., 2006).
Oligomer-size assignments can be verified by measuring high-resolution mass
spectra for each peak in the ATD. For example, Figure 4.4 shows the mass spectrum
obtained for the most prominent feature in the Man5GlcNAc2 ATD shown in Figure
4.3. This ATD feature gives a 13C-isotope pattern with 1 Da spacings,
unambiguously indicating a singly-charged species, the monomer. Similarly,
doubly-charged dimers would give 0.5 Da spacings, triply-charged trimers, 0.33 Da
spacings, etc. The ability to obtain MS and MS/MS spectra for each ATD observed
in the experiment is an important aspect of this instrument that allows significantly
more confident assignment of the source of features in ATDs.
Figure 4.4: Mass
obtained frospectrum of the singly charged monomer of Man5GlcNAc2
m the most prominent feature in the m/z selected ATD
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Reproducibility of separation of common glycans from different
sources
To address whether the glycan source has an impact on the reproducibility of the
separation, glycan Man5GlcNAc2 released from four different sources:
ribonuclease B, chicken ovalbumin, porcine thyroglobulin and desialylated
thyroglobulin was studied with TWIM-MS. Figure 4.5 shows ATDs for m/z 1257,
the [M + Na]+ ion, obtained from each source. The arrival times were 7.20 to
7.28 ms and reproducible to within one scan (± 80 µs) for all experiments. The 1 %
difference between the top two scans and the bottom two scans is within
experimental error. This demonstrates the independence of arrival time to other
components within the complex glycan mixtures.
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ented in this paper, from complex released glycan mixtures to
ards, were reproducible to within one scan (± 80 µs) over
. This excellent reproducibility, combined with MS and
s high confidence in the ability to identify structures from
eric Glycan Structures
positive ion ESI mass spectrum obtained for glycans released
umin, which is dominated by sodiated glycan species,
2, (n = 0, 1, 2), is similar to one obtained previously using
esorption ionization (MALDI) (Harvey et al., 2000). The ion
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mobility separation and mobility-resolved MS/MS capabilities of the Synapt
instrument give it great potential as a tool in investigating the structures and
conformations of these glycans. If linkage isomers with different mobilities exist for
a particular glycan we should be able to detect them by measuring an ATD.
Likewise, information on conformers could be obtained if their mobilities are
sufficiently different. Further information can be provided by measuring mass
spectra for particular ATD features.
A review of oligosaccharide conformation studies by Wormald and co-workers
(Wormald et al., 2002) indicates that different conformations can arise through
rotation about Man-Man linkages. The three dominant glycan peaks seen in our
ovalbumin mass spectrum each have one Manα1-3Man link and one Manα1-6Man
link. The reviewed experimental and modelling studies indicate that the 1-3 link is
flexible and that any different stable conformations present rapidly interconvert. The
data available on the 1-6 link is less consistent. Analysis of existing crystal structures
indicates that this link tends to take on three major and one minor conformation.
NMR and modelling of a trisaccharide containing a Manα1-6Man link indicate two
stable conformations, while modelling of Man9GlcNAc2 indicates the two Manα1-
6Man links present each prefer a different single conformation.
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he core glycan Man3GlcNAc2 should have only one linkage isomer as shown in
igure 4.6 (Egge et al., 1983; Yamashita et al., 1983). It is possible that this glycan
as up to three significant conformers due to rotation around the Manα1-6Man link
ince the Manα1-3Man link is not expected to take on distinct conformations). The
ifferences in cross section of the potential conformers might not be significant since
nly one sugar group is being moved by rotation about the 1-6 link. The ATD
easured for the m/z 933 mass spectrum peak (Figure 4.6) supports this contention
nce it has only a single, narrow feature. This result agrees well with the results of a
CIMS study of glycans released from ovalbumin by Plasencia et al. (Plasencia et
l., 2008). They find a single peak in their drift time distribution for permethylated,
oubly-sodiated Man3GlcNAc2.
or GlcNAc1Man3GlcNAc2, there is the possibility of multiple linkage isomers
epending on where the third GlcNAc group is added. Again there is potential for
nformers due to rotation about the Manα1-6Man link. These conformers may have
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significantly different cross sections if the third GlcNAc group binds to the 1-6
branching Man group, since the 1-6 rotation would be moving this capping GlcNAc
group. The ATD for the m/z 1136 peak is shown in Figure 4.6 and has two dominant
features.
To help identify these two species, mobility-resolved MS/MS spectra (using the
transfer region of the Synapt instrument) have been obtained for the two ATD
features. Positive ion (sodium attachment) spectra for the two ATD features (data not
shown) did exhibit some differences. In particular, differences in the relative
intensities of peaks at m/z 399.2 corresponding to a sodiated ManGlcNAc group and
m/z 933.4 corresponding to the loss of a single GlcNAc group would suggest
different linkage isomers. The positive ion data alone was not enough to identify the
species associated with the two ATD features. Mobility-resolved MS/MS spectra
were also obtained for phosphate attachment and were more helpful. These negative
ion spectra shown in Figure 4.7 are notated using the carbohydrate nomenclature
introduced by Domon and Costello. (Domon and Costello, 1988) Fragment ions that
contain a non-reducing terminus are labelled with uppercase letters from the
beginning of the alphabet (A, B, C), and those that contain the reducing end of the
oligosaccharide are labelled with letters from the end of the alphabet (X, Y, Z);
subscripts indicate the cleaved ions. The A and X ions are produced by cleavage
across the glycosidic ring, and are labelled by assigning each ring bond a number and
counting clockwise. Ions produced from cleavage of successive residues are labelled:
Am, Bm and Cm, with m = 1 for the non-reducing end and Xn, Yn, and Zn, with n = 1
for the reducing-end residue.
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he negative ion MS/MS data also indicate that the two features in the ATD
epresent two different linkage isomers of GlcNAc1Man3GlcNAc2. These results
llow the structures to be unambiguously assigned. The mass spectrum obtained for
e 5.76 ms feature in the ATD is shown in Figure 4.7a. It has peaks at
/z 323 and 305, which can be assigned as the D and D-18 fragments, respectively,
rom the isomer with the capping GlcNAc group bound to the Man group of the 1-3
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branch. The 1-3A2α fragment at m/z 262 in the spectrum indicates that this capping
GlcNAc group is bound by a β1-2 linkage. (Harvey, 2005) The mass spectrum for
the 6.48 ms ATD feature (Figure 4.7b) has peaks at m/z 526 and 508. These D and
D-18 fragment masses correspond to the isomer with the capping GlcNAc group
bound to the man group of the 1-6 branch, again by a β1-2 linkage as indicated by
the 1,3A2α fragment at m/z 262.
Since the two features in the GlcNAc1Man3GlcNac2 ATD can be assigned to linkage
isomers, there is no evidence for the presence of different conformers. Multiple
conformers may exist in our experiment but if they are present they either
interconvert rapidly on our experimental time scale or have very similar cross
sections. A high-resolution DCIMS instrument may be able to distinguish
conformers. Plasencia et al.(Plasencia et al., 2008) found four features in the drift
time distribution for permethylated, double sodiated Man3GlcNAc3 with associated
cross sections ranging from approximately 292 – 328 Å2.
For GlcNAc2Man3GlcNAc2, there is again the possibility of linkage isomers as well
as conformers. As shown inFigure 4.6, the mass spectrum peak at m/z 1339 gives an
ATD single feature centred around 7.60 ms. While this ATD feature is broader than
that obtained for Man3GlcNAc2, an increase in the spread of arrival times is expected
due to the later average arrival time of GlcNAc2Man3GlcNAc2 and does not
necessarily indicate the presence of multiple isomers or conformations. Plasencia et
al. (Plasencia et al., 2008) also found only one feature in their drift time distribution
for the permethylated, doubly-sodiated version of this glycan. MALDI MS
experiments (Harvey et al., 2000) have suggested that there are two linkage isomers
possible for this species with a GlcNAc residue bisecting the trimannose subunit and
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another bound to either the Manα1-3Man or Manα1-6Man branch, while an NMR
study (Da Silva et al., 1995) finds only the first isomer. The MS/MS data acquired
for this species (not shown) reveals no evidence for the bisecting GlcNAc residue
(Harvey, 2005). One linkage isomer with a GlcNAc residue bound to the 1-3 branch
and another to the 1-6 branch would be in better agreement with our observation of a
single-peak ATD and the corresponding MS/MS results.
The set of experiments described in this section is an example of the high
information content of the TMIM-MS/MS experiment. Mobility separation, mass
spectra and product ion mass spectra can all be acquired in a single experiment.
Comparison of the TWIMS and DCIMS methods
The measurement of absolute cross sections is currently impossible using the
TWIMS approach due to the very complex path the ions take as they traverse the
mobility cell. TWIMS results can however be successfully calibrated against cross
sections of compounds measured in a DCIMS device. The resulting estimated cross
sections have been shown to be in good agreement with those measured using the
established drift cell approach (Ruotolo et al., 2005; Scarff et al., 2008; Williams and
Scrivens, 2008). Here we compare values measured using DCIMS to those
estimated using TWIMS for a series of oligosaccharides: BP-S and iso-BP-S; LNFP I
and LNFP V; and finally LNDFH I and LNDFH II (Table 4.1).
All of these systems have been examined using the DCIMS instrument at UC Santa
Barbara (Wyttenbach et al., 2001). In each instance a strong sodiated parent ion was
present in the mass spectrum, and for each of these cases a single symmetric ATD
was observed (data not shown). Experimental cross sections determined in each case
are listed in Table 4.3. Molecular modelling calculations revealed a single family of
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low-energy structures for each oligosaccharide. Representative structures, with the
experimentally obtained cross sections, are shown in Figure 4.8 along with the
corresponding average theoretical cross sections for each family of structures. The
theoretical cross sections are also listed in Table 4.3. Several aspects of these results
deserve comment. First, there is excellent agreement between experiment and theory
in all cases. The Na+ ions were randomly placed on the molecules during simulated
annealing runs and the same families of low-energy structures always emerged.
Second, the BP-S and iso-BP-S structures observed are very similar, consistent with
the identical experimental cross sections. The other two sets of sodiated isomers
have quite different structures yet they also have nearly identical cross sections. This
example provides a caution that the observation of very similar cross sections does
not necessarily imply the presence of similar conformations.
Table 4.3. Experimental and Theoretical Results for Penta- and
DCIMS Theory TWIMS
Oligosaccharide Cross Cross Arrival Est. Cross
[BP-S + Na]+ 185 186 3.20 185
[iso-BP-S + Na]+ 185 190 3.20 185
[LNFP I + Na]+ 196 194 3.65 196
[LNFP V + Na]+ 194 196 3.51 193
[LNDFH I + Na]+ 217 216 4.50 217
[LNDFH II + 214 217 4.28 211
[LNFP I + H]+ 185, 201 – 3.15, 3.87 184, 201
[LNFP V + H]+ 195 – 3.47 191
a Estimated from calibration
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six oligosaccharides was examined using the TWIM-MS device and
tributions obtained (data not shown). The corresponding average
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arrival times are given in Table 4.3. Essentially identical arrival times were obtained
for sodiated BP-S and iso-BP-S. Sodiated LNFP I and LNFP V also have very
similar arrival times, and to a lesser extent, so do LNDFH I and II. It has been
shown that the TWIM-MS device can be calibrated using cross sections measured
with a DCIMS instrument. It is important that calibration is carried out under
identical TWIMS experimental conditions and using DCIMS calibration values that
bracket the mobilities of interest (Shvartsburg and Smith, 2008). The calibration
method has been described in Chapter and elsewhere (Thalassinos et al., 2009). It
entails comparing corrected effective TWIMS drift times to DCIMS cross sections.
The estimated TWIMS cross sections are given in Table 4.3 along with the absolute
cross sections measured using DCIMS, the cross sections derived from the molecular
modelling structures and the arrival times from TWIMS. The [BP-S + Na]+ ion was
used as the reference for calibration. Good agreement is obtained between the
absolute DCIMS values and the estimated values from the TWIM-MS device.
The LNFP I and LNFP V systems have significant protonated parent peaks, in
addition to the sodiated peaks seen for the other species. It should be noted the
protonated peak in the mass spectrum of the DCIMS instrument was quite weak
while the same peak was quite strong on the TWIM-MS instrument. The differences
in spray methods and sampling, together with intrinsic sensitivity differences could
account for this observation. While the ATDs for all the sodiated oligosaccharides
and protonated LNFP V have just a single peak, the protonated LNFP I ATD has an
additional feature as shown by both the DCIMS and TWIMS approaches (a and b).
The corresponding DCIMS cross sections for protonated LNFP I and V are given in
Table 4.3 along with the TWIMS arrival times and estimated cross sections, which
agree well with the DCIMS values. The additional ATD feature for protonated
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LNFP I was initially thought to represent another conformer. Using the capability of
the Synapt to obtain MS/MS data on mobility separated compounds, MS/MS spectra
were obtained in the transfer region for both ATD features. The results are given in
Figure 9 c and d, which show product ion spectra of m/z 854 for both species. The
mass spectrum for the later ATD feature (Figure 4.9d) is consistent with the simple
fragmentation pattern expected for oligosaccharides in positive ion mode and is
similar to a positive-ion ESI mass spectrum obtained by Levin et al. (Levin et al.,
2007). The mass spectrum for the earlier ATD feature (C) has a much more
complicated fragmentation pattern and is unlikely to be a result of a second
conformation of LNFP I but rather an isomer or some other impurity. Unlike our
bimodal ATD, the LNFP I differential mobility spectrum measured by Levin and co-
workers has only one peak.
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Conclusions
The ion mobility separation characteristics of the TWIMS device have been shown to
be similar to the DCIMS device, although the theoretical relationship between
measured arrival times and mobility has not yet established for the travelling wave
technique. Previous work has indicated that mobility calibration of the TWIMS is
possible using species of known collision cross section (Ruotolo et al., 2005; Scarff
et al., 2008; Williams and Scrivens, 2008). This method has been successfully
applied during this study. While the resolving power of the TWIMS is not as high as
some DCIMS systems the separation capability is valuable for reducing mass
spectral complexity, as shown for the complex released glycans. A particular
advantage of the Synapt instrument over most DCIMS configurations is that the
radial ion confinement in the mobility cell increases the overall instrument
sensitivity, allowing investigations on analytically significant (fmol) levels of
sample. This work illustrates that the TWIMS device provides rapid, sensitive and
information-rich experimental data for the analysis of complex mixtures of glycans.
The arrival times obtained are reproducible and independent of the source of the
glycan. Some isomeric glycans can be separated and characterized using MS/MS
experiments in favourable circumstances. The TWIMS device shows significant
promise for screening complex glycan samples and for many other analytical
applications in the characterization of biological systems.
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Summary of Project and Future Directions
The work undertaken in this thesis described a number of examples of the use of
recently developed mass spectrometry experimental approaches to characterise
biologically important mixtures. Ambient ionisation techniques and ion-mobility
mass spectrometry have been demonstrated to improve the rate of analysis of a range
of sample types including pharmaceuticals and complex mixtures of carbohydrates
while maintaining the high sensitivity, selectivity and information content provided
by traditional mass spectrometry-based approaches.
Ambient Ionisation
The field of ambient ionisation has continued to grow since DESI was first reported
in 2004. A number of research groups are continuing work on existing ionisation
sources, and their potential applications.
Recently introduced ambient ionisation mass spectrometry approaches have been
utilised in the rapid, sensitive, information rich characterisation of pharmaceutical
formulations. Little, or no, sample treatment was required and the experiments were
shown to provide detailed information on active ingredients in the presence of a
number of other components. A range of pharmaceutical formulations were analysed
containing active ingredients in the molecular weight range of 150 – 750 Da. A
number of ambient ionisation approaches including DART, DESI and DAPCI were
compared and advantages and disadvantages of each approach outlined and
discussed.
The potential future use of these ambient ionisation approaches is wide ranging.
Ambient ionisation sources are being produced as commercial products by some
instrument manufacturers, including the DART source (JEOL, Peabody, MA, USA)
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and a commercial DESI source (Prosilia Inc., Indianapolis, IN, USA). Some
applications for which they may be amenable for routine use are the detection of
explosives and drugs (with significant potential when coupled with lightweight
portable mass spectrometers), and imaging of tissues and surfaces for spatially
resolved mass spectral information.
Ion Mobility-Mass Spectrometry of Carbohydrates
The exciting technology of travelling wave-based ion mobility has recently been
commercially interfaced with mass spectrometry. This has been utilised in a series of
fundamental experiments that probe the interaction of varied cations with isomeric
oligomers of carbohydrates. The approach enables conformational changes to be
rapidly measured over a wide (500-6000 Da) mass range. Changes in conformations
were observed for multiply cationised species which agree with previously measured
solution phase measurements. Potential future work in this area includes the
investigation of additional polymers, alternative cations, the behaviour of
carbohydrate polymers in negative ionisation mode, and extended mass range
experiments to further characterise carbohydrate behaviour in TWIM-MS.
The TWIM-MS approach has also been used successfully to characterise a number of
N-linked glycans released from glycoproteins. The experiments enable some
isomeric structures to be differentiated. Estimated cross sectional measurements have
been calculated and found to be in good agreement with those obtained from
conventional drift cell approaches. The TWIM-MS and –MS/MS based analysis of
glycans may provide the opportunity to develop methods for the rapid, high
information content, batch-to batch characterisation of glycosylated
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biopharmaceutical products, and detection of a range of diseases and disorders that
present diagnostic markers in the form of changes in glycosylation profile.
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E-mail: j.Three ionisation techniques that require no sample preparation or extraction prior to mass analysis
have been used for the rapid analysis of pharmaceutical tablets and ointments. These methods were
(i) the novel direct analysis in real time (DART), (ii) desorption electrospray ionisation (DESI), and
(iii) desorption atmospheric pressure chemical ionisation (DAPCI). The performance of the three
techniques was investigated for a number of common drugs. Significant differences between these
approaches were observed. For compounds of moderate to low polarity DAPCI produced more
effective ionisation. Accurate DESI andDAPCI tandemmass spectra were obtained and these greatly
enhance the selectivity and information content of the experiment. The detection fromhuman skin of
the active ingredients from ointments is reported together with the detection of ibuprofen metab-
olites in human urine. Copyright # 2006 John Wiley & Sons, Ltd.Desorption electrospray ionisation (DESI) is a newly
developed ionisation technique for the analysis and detec-
tion of samples present on a variety of surfaces.1 Rapid high-
throughput analysis can be undertaken for a variety of
sample types. The technique can be used to detect analytes
on surface areas of sub-mm2 dimensions. Applications
utilising the DESI technique include the detection of
rhodamine dyes and pharmaceutical samples separated on
thin-layer chromatography (TLC) plates,2 the rapid detection
of pharmaceutical samples using ion mobility/time-of-flight
mass spectrometry (ToFMS),3 high-throughput analysis of
pharmaceutical samples,4 the detection of explosives,5,6 the
rapid accurate mass tandem mass spectrometry (MS/MS) of
pharmaceutical samples,7 intact biological tissue imaging,8
direct analysis of alkaloids from plant tissue,9 and the
analysis of controlled substances.10,11 Several possible
mechanisms of ionisation have been postulated, including
chemical sputtering involving gas-phase ions generated by
electrospray ionisation (ESI) or corona discharge and
subsequent charge transfer between these primary ions
and sample molecules on the surface. The occurrence of gas-
phase ion-molecule reactions has also been suggested
together with a droplet splashing or pick-up mechanism.
This involves the impacting of multiply charged solvent
droplets dissolving sample molecules from the surface
leading to the formation of secondary charged droplets
carrying sample molecules and resulting in ion formation
mechanisms similar to that of ESI.1,4–6
Desorption atmospheric pressure chemical ionisation
(DAPCI) was first reported for the trace level detection ofndence to: J. P. Williams, Department of Biological
University of Warwick, Gibbet Hill Road, Coventry
, UK.
p.williams@warwick.ac.ukTNT, PETN and RDX explosives,5 and has not received as
much attention to date as DESI. Ionisation of the explosives
was provided by the initial formation of toluene or methanol
reagent ions produced by a corona discharge. These reagent
ions formed are thought to ionise the analyte molecules by
either electron or proton transfer in a chemical ionisation
step.5 For those compounds that do not provide sufficient ion
intensity by DESI, DAPCI offers an alternative option.
DAPCI has been shown to provide increased sensitivity for
compounds of moderate polarity.7 DAPCI generated higher
signal intensities for the active ingredient hydrocortisone, a
weakly polar corticosteroid, than DESI using the same
solvent system normally used for conventional ESI exper-
iments.7 The DAPCI technique previously reported7 used
nitrogen sheath gas and a mixture of methanol/water (1:1)
from which ions were produced by a corona discharge.
Reagent ions formed in the corona discharge region react
with desorbed analyte molecules forming, depending on the
ionisation mode, for the most part, protonated or deproto-
nated molecules.7 A variant to the DAPCI technique for the
rapid analysis of volatile and semi-volatile compounds,
referred to as atmospheric pressure solids analysis probe
(ASAP), was recently used in the analysis of a number of
steroids and biological tissues.12 Vapourisation of the sample
is accomplished by placing it within the hot flowing nitrogen
gas at atmospheric pressure.
Another rapid and newly developed ionisation method,
direct analysis in real time (DART), was recently reported.13
Pharmaceutical samples, explosives and metabolites in urine
were analysed on a single ToF instrument. Sample analysisCopyright # 2006 John Wiley & Sons, Ltd.
1448 J. P. Williams et al.by the DART technique is carried out at ambient temperature
and ionisation is brought about by exposing the sample to a
stream of excited gas, typically helium. An electrical
discharge produces ions, electrons and excited state
metastable neutral species. Several ionisation mechanisms
have been postulated, including Penning ionisation, in which
ionisation of the sample occurs by energy transfer from an
excited atom or molecule of energy greater than the
ionisation energy of the sample.13 It was reported that when
helium is used as the gas, the mechanism involves the
formation of ionised water clusters followed by proton
transfer reactions.13
In this present study we have made use of these three
newly developed ionisation techniques. The main focus of
this study was to evaluate the potential of the ionisation
techniques for the rapid analysis of active ingredients
formulated into a variety of pharmaceutical tablets, gels
and ointments. The rapid analysis of pharmaceutical drug
formulations, the detection from human skin of the active
ingredients from ointments or gels, and the detection of
ibuprofen metabolites in human urine have been carried out.
The increased selectivity and specificity of the DESI and
DAPCI techniques used with a hybrid quadrupole ToF
instrument were compared with that obtained by the use of
DART with a single ToF instrument. Accurate mass MS and
accurate mass MS/MS measurements, to within 2mTh, has
allowed elemental compositions for the product ions to be
determined, thereby facilitating the identification of frag-
mentation pathways. We believe this to be the first report
exploiting all three newly developed ionisation techniques
combined with accurate mass DAPCI-MS/MS.EXPERIMENTAL
The tablets and ointment formulations investigated are listed
in Table 1, together with the molecular formulae and
molecular weights of the active ingredients. Ibuprofen tablets
and gel (Tesco, UK), Anadin Extra (Wyeth, UK) and
Solpadeine Max (Tesco, UK) were purchased without
prescription fromapharmacy. Proctosedyl ointment (Aventis)Table 1. Structures, molecular formulae and molecular weights o
Copyright # 2006 John Wiley & Sons, Ltd.and metoclopramide (APS) were obtained by prescription.
Solvents were obtained from Sigma-Aldrich (Poole, UK).
Mass spectrometry
DART experiments were carried out on an AccuToF LC ToF
mass spectrometer (Jeol, Peabody, MA, USA) and DESI/
DAPCI experiments were carried out on a Q-ToF I (Waters,
Manchester, UK). Experimental conditions for each are given
below.
DART
A detailed description of the DART source can be found
elsewhere.13 The AccuToF instrument was operated with
helium flowing into the DART source and a voltage of 2 kV
applied to the discharge needle in positive mode of
ionisation. Orifice 1 of the interface was set to 27 eV. This
voltage can be increased or decreased depending on the
amount of fragmentation desired. The gas temperature was
maintained at 808C and the operating resolution of the
instrument was approximately 6000 (FWHM). Mass spectra
were acquired over the mass range of m/z 50–500 at an
acquisition rate of 0.5 spectrum/s. For DART sample
analysis the helium gas was directed towards the sample
or allowed to interact with vapour-phase samples. Tablets
were broken, to expose an uncoated sample surface, before
being held with tweezers in the path of the flowing helium at
atmospheric pressure. Samples in solution were analysed by
placing filter paper (1 cm 8 cm) in the solution prior to
being held similarly. For ointments, approximately 100mg
was applied to the surface of a piece of matt-finished
cardboard (1 cm 2 cm) and held in the same position.
DESI
The Q-ToF I instrument was operated in positive and
negativemodewith a capillary voltage of 3.5 kV and3.2 kV.
The ion source block and nitrogen desolvation gas tempera-
tures were set to 1008C and 4008C and the desolvation gas
was set to a flow rate of 300 L/h. The cone voltage was set at
20V for MS and MS/MS experiments and the collision
energy used for MS/MS experiments was ramped betweenf the compounds investigated
Rapid Commun. Mass Spectrom. 2006; 20: 1447–1456
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was operated at a resolution of approximately 6000 (FWHM),
with spectra acquired over themass range ofm/z 50–500 at an
acquisition rate of 1 spectrum/s. For all MS/MS experiments
argon was used as the collision gas. For DESI sample
analysis, each tablet was broken, to expose an uncoated
sample surface, before being held with tweezers, at an angle
of approximately 458 to the solvent spray and a distance of
5mm from the source sampling cone. Approximately 100mg
of the ointment was applied to the surface of a piece of matt-
finished cardboard (1 cm 2 cm) and held in the same
position as the solid tablets. The surface of the tablet or card
was then sprayed with a solution of acetonitrile/H2O (1:1) in
negative mode and a solution of acetonitrile/H2Oþ 0.2%
formic acid in positive mode at a flow rate of 10mL/min,
using a model 22 syringe pump from Harvard Apparatus
(South Natick, MA, USA). No extensive modification of
solvents, buffers and pH was carried out.
DAPCI
DAPCI experiments were performed on the Q-ToF I in both
positive and negative modes of ionisation. The corona
discharge pin voltage was set to 3.5 kV and 3.0 kV in
positive and negative modes, respectively. The cone voltage
was optimised between 10 and 25V for each sample. The
collision energy used for MS/MS experiments was ramped
between 10 and 25 eV during the acquisition. The flow rate of
the nitrogen desolvation gas was set to 150L/h. The source
and probe temperatures were set to 1008C and 4008C,
respectively. A solvent mixture of methanol and water (1:1)
flowing at 10mL/min was infused into the heated nebuliser
probe where it was converted into an aerosol which was
rapidly heated in a stream of nitrogen gas, forming a vapour
at the probe tip. The probe tip directly faced the tablet or
ointment (which had been deposited onto the card)
positioned between the corona discharge pin and the
sampling cone. Reagent ions formed in the corona discharge
region reacted with desorbed analyte molecules from the
tablet or card forming, depending on the ionisation mode, for
the most part, protonated or deprotonated molecules. The
same experiments were also performed without any solvent
flowing into the heated probe. This solventless DAPCI
experiment is similar to the ASAP experiment previously
described.12
Accurate mass measurement protocol
for the Q-ToF I
Instrumental mass drift was corrected for by using a single
internal reference lock mass in MS and MS/MS mode on the
Q-ToF. Since the target compounds in this study are known,
the precursor ion selected for MS/MS experiments provided
the internal reference lock mass in MS/MS mode. Data
acquisition and processing were carried out using the digital
dead-time correction algorithm embedded in the operating
software,MassLynx (V3.5), supplied byWaters UK. The high
ion counts generated using the DAPCI and DESI techniques
caused time-to-digital (TDC) dead-time saturation.7 The
TDC correction software was utilised and displayed a peak
centroid with the correct mass and signal intensity.Copyright # 2006 John Wiley & Sons, Ltd.RESULTS AND DISCUSSION
An investigation has been carried out of a number of
prescription and non-prescription pharmaceutical formu-
lations. Active ingredients from a gel applied to human skin
and drug metabolites in human urine were also investigated.
DART, DESI and DAPCI (solvent/solventless) techniques
were employed. The DESI and DAPCI techniques can be
used as a rapid screen for the analysis of solids and liquids
and can be set up quickly onmost instruments by the use of a
home-built source,1,10 or where the samples are handled
manually.7,11 The relative signal intensities of the active
ingredients are different when samples are held manually.
This is due to the non-reproducibility of positioning of the
sample in the solvent spray. The use of these techniques for
the rapid analysis of samples provides similar information to
that provided by the DART source. The active ingredients
formulated in the solid tablets were detected by the DART
technique and the analysis time in MS mode of operation
was, for the majority of samples, as rapid as in the DESI and
DAPCI techniques, requiring, in most cases, less than 5 s.
The analysis of solid tablets and the identification of
ranitidine metabolites in human urine using the DART
source have previously been reported.13 Since DAPCI has
received little attention, a representative sample of results
will focus on this together with others obtained using DESI.
A comparison of the three techniques is made for the
detection of a range of drugs. Tandem mass spectrometry
(MS/MS) was performed on either the protonated or
deprotonated molecule. The ion selected for collision-
induced dissociation (CID) using the DAPCI and DESI
techniques is annotated with a filled black circle and
included in each figure for clarity. Some of the fragmentation
pathways are complex and a detailed description of these has
not been included. The proposed fragmentation schemes for
some of the molecules are not assumed to be sequential. MS/
MS of the protonated molecule [MþH]þ of nicotine, for
example, forms a product ion at m/z 106. This ion could
possibly be formed by more than one route; m/z 163! 106
(loss of C3H7N) or m/z 163! 132! 106 (sequential loss of
CH3NH2 and C2H2).
Analysis of solid tablets in positive ion DAPCI,
DESI and DART mode
A solid Anadin Extra tablet, which contained 45mg of
caffeine, 200mg of paracetamol and 300mg of aspirin, was
analysed by DAPCI, DESI and DART. The mass spectra
obtained for Anadin Extra using the DAPCI, DESI and the
DART sources are shown in Figs. 1(A)–1(C). The protonated
molecules for each of the active ingredients, paracetamol at
m/z 152, aspirin at m/z 181 and caffeine at m/z 195, were
observed in the DAPCI and DESI mass spectra but the
protonated aspirin molecule was absent in the DART
spectrum. The base peak in all the spectra is m/z 195,
protonated caffeine. Accurate mass measurement confirms
that the ion at m/z 163 is formed by loss of H2O from
protonated aspirin. This ion was observed in all three spectra.
The ion at m/z 198 in the DAPCI and DESI spectra is
ammoniated aspirin, [MþNH4]þ, m/z 203 in the DESI
spectrum is sodiated aspirin, [MþNa]þ. Figure 1(D) showsRapid Commun. Mass Spectrom. 2006; 20: 1447–1456
DOI: 10.1002/rcm
Figure 1. (A) Positive ion DAPCI-MS spectrum of an Anadin Extra tablet.
(B) Positive ion DESI-MS spectrum of an Anadin Extra tablet. (C) Positive ion DART
MS spectrum of an Anadin Extra tablet. (D) Positive ion DAPCI accurate mass MS/
MS spectrum obtained from the protonated molecule of caffeine, [MþH]þ ofm/z 195.
1450 J. P. Williams et al.the accurate mass MS/MS spectrum obtained for protonated
caffeine. The elemental composition assignments for the
product ions obtained for caffeine are given in Table 2. The
base peak in the MS/MS spectrum is m/z 138. The MS/MS
spectrum obtained during this study is very similar to that
obtained previously.14 Elemental composition assignment
shows that the protonated molecule primarily fragments by
the loss of methyl isocyanate (57Da) forming an even-electron
ion at m/z 138 with the formula of C6H8N3O. Two other
product ions were generated with sufficient ion counts for the
generation of elemental formulae: m/z 121 is an odd-electron
radical cation with probable formula of C5H3N3O and the ion
at m/z 110 has the elemental formula of C5H8N3 formed
through loss of CO from m/z 138.
A SolpadeineMax tablet containing 500mg of paracetamol
and 12.8mg of codeine phosphate was analysed. The mass
spectra obtained using the DAPCI, DESI and DART sources
are shown in Figs. 2(A)–2(C). The m/z 152 base peak in the
DAPCI andDART spectra is fromprotonated paracetamol. The
base peak in the DESI spectrum is the dimer [2MþH]þ at
m/z 303 from paracetamol. The formation of dimers has been
observed in all three techniques and is related to the local
concentration of the active ingredient under study. The ratio of
monomer to dimer species can vary with the exposed part of
the tablet under investigation. The protonated molecule from
codeine was more abundant than the protonated dimer of
paracetamol using DART. The reverse was observed forTable 2. DAPCI-MS/MS accurate mass of m/z 195 [MþH]þ
of caffeine
Measured mass Formulae Error (mTh)
138.0675 C8H10O2 0.6
C6H8N3O 0.8
121.0293 C7H5O2 0.4
C5H3N3O 1.7
110.0729 C6H10O 0.3
C5H8N3 1.1
Copyright # 2006 John Wiley & Sons, Ltd.DAPCI and DESI. Other minor ions observed in the spectra are
probably due to additives in the tablet formulation. The MS/
MS spectrum of protonated codeine is shown in Fig. 2(D). The
product ion spectrum generated from protonated codeine can
be seen to be very complex but it is also specific and
reproducible. The elemental composition assignments for some
of the product ions obtained for codeine are given in Table 3.
Analysis of the active ingredients of a gel
formulation by desorption from human skin by
DESI
A thin layer of Ibuprofen gel containing 5%w/wof the active
ingredient was applied to the surface of a human finger. The
gel was gently massaged until absorbed by the skin. Using
the DESI technique, with a source and desolvation
temperature of 1008C, one could readily detect the drug at
the point of application. Figure 3(A) shows the negative DESI
mass spectrum, generated in 2 s, obtained 20min after
applying the gel. The base peak in the spectrum is
deprotonated ibuprofen. Figure 3(B) shows the accurate
mass MS/MS spectrum obtained for the deprotonated
ibuprofen molecule 20min after applying the gel. The
deprotonated ibuprofen, [M–H] at m/z 205.1229, was used
as the internal lock mass. Accurate mass measurement of the
product ion atm/z 161.1321 confirms that CO2 is lost from the
deprotonated molecule. This ion has an empirical formula of
C12H17, a mass difference of 0.9mTh from the theoretical
monoisotopic mass. [Caution: there is a risk of electric shock from
the capillary. Although the capillary carries only limited current, it
is advisable to keep the finger well away from the capillary tip in the
experiment].
Comparison of DART/DESI/DAPCI for the
detection of two active ingredients in
Proctosedyl ointment
It has been previously demonstrated that the detection of the
two active ingredients formulated into proctosedyl ointment,
cinchocaine hydrochloride (5mg/g) and hydrocortisoneRapid Commun. Mass Spectrom. 2006; 20: 1447–1456
DOI: 10.1002/rcm
Figure 2. (A) Positive ion DAPCI-MS spectrum of a Solpadeine Max tablet.
(B) Positive ion DESI-MS spectrum of a Solpadeine Max tablet. (C) Positive ion DART
MS spectrum of a Solpadeine Max tablet. (D) Positive ion DAPCI accurate mass MS/
MS spectrum obtained from the protonated molecule of codeine, [MþH]þ of m/z 300.
Rapid analysis of pharmaceuticals by DART, DESI and DAPCI 1451(5mg/g), was better with DAPCI than with DESI exper-
iments. In positive ion mode, hydrocortisone, a weakly polar
corticosteroid, was more effectively ionised by DAPCI.7
During this investigation, the ointment was applied to the
card in the usual way and investigated in both negative and
positive ion DAPCI modes of operation. The mass spectrum
obtained for the ointment in negative ion mode is shown in
Fig. 4(A). High ion counts were generated, highlighting the
sensitive response of the ointment to the DAPCI process in
negative mode. The base peak in the spectrum is the
deprotonated molecule of cinchocaine at m/z 342. Other ions
observed in the spectrum arise from additives in the
ointment formulation. No ion was observed for deproto-
nated hydrocortisone. The mass spectrum obtained for the
ointment in positive ion mode is shown in Fig. 4(B). High ion
counts were generated, highlighting the sensitive response of
the ointment to the DAPCI process in positive ion mode. The
base peak in the spectrum is protonated cinchocaine
at m/z 344. The ion at m/z 363 corresponds to protonated
hydrocortisone.
The product ion spectra of the deprotonated and
protonated molecules of cinchocaine can be compared in
Figs. 4(C) and 4(D). Figure 4(C) shows the negative ion
accurate mass MS/MS spectrum obtained for deprotonated
cinchocaine. The elemental composition assignments for the
product ions are given in Table 4. The base peak in the MS/
MS spectrum is formed by the loss of C7H14N2O from the
deprotonated molecule to the ion at m/z 200. This ion furtherTable 3. DAPCI-MS/MS accurate mass of m/z 300 [MþH]þ
of codeine
Measured mass Formulae Error (mTh)
266.1196 C17H16NO2 1.5
225.0922 C15H13O2 0.6
215.1094 C14H15O2 2.2
199.0765 C13H11O2 0.6
183.0800 C13H11O 0.9
Copyright # 2006 John Wiley & Sons, Ltd.fragments to m/z 144 by loss of 56Da. Accurate mass
measurement confirms this to be a loss of C4H8. A proposed
fragmentation scheme is shown in Fig. 4(E).
Figure 4(D) shows the positive ion accurate mass MS/MS
spectrum obtained for protonated cinchocaine. The probable
elemental composition assignments for the product ions are
given in Table 5. The base peak in the MS/MS spectrum is
formed by the loss of C4H11N from the protonatedmolecule to
the ion atm/z 271. This ion further fragments tom/z 215 by loss
of 56Da. Accurate mass measurement confirms this to be a
loss of C4H8. A proposed fragmentation scheme is shown in
Fig. 4(F).Figure 3. (A) Negative ion DESI-MS spectrum of Ibuprofen
gel desorbed off skin. (B) Negative ion DAPCI accurate mass
MS/MS spectrum obtained from the deprotonated molecule of
ibuprofen, [M–H] of m/z 205.
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Figure 4. (A) Negative ion DAPCI-MS spectrum of Proctosedyl ointment. (B)
Positive ion DAPCI-MS spectrum of Proctosedyl ointment. (C) Negative ion DAPCI
accurate mass MS/MS spectrum of m/z 342, the deprotonated molecule [M–H] of
cinchocaine hydrochloride. (D) Positive ion DAPCI accurate mass MS/MS spectrum
of m/z 344, the protonated molecule [MþH]þ of cinchocaine hydrochloride.
(E) Proposed negative ion fragmentation pathway of [M–H] of cinchocaine hydro-
chloride. (F) Proposed positive ion fragmentation pathway of [MþH]þ of cinchocaine
hydrochloride.
1452 J. P. Williams et al.The detection of active ingredients in ointments and creams
using this approach is non-labour-intensive since the analysis
requires no prior analyte extraction. A comparison of the DESI
and DAPCI (solvent and solventless) techniques was made for
this ointment since it contained both polar and weakly polar
ingredients. Figure 5 shows the comparison. The mass
spectrum of each is shown over the m/z region of 300–400.
The top spectrum was obtained using DESI, the middle
spectrum obtained using DAPCI without the use of solvent,
and the bottom spectrum was obtained using DAPCI with
solvent flowing into the heated probe. Protonated molecules
were detected for both cinchocaine (m/z 344) and hydrocor-
tisone (m/z 363) by all three techniques. The top two spectra
have been magnified (16) over the m/z region for hydrocor-
tisone. The [MþH]þ ion fromcinchocaine is the base peak in all
three spectra showing that this compound ionises more
efficiently than hydrocortisone. The hydrocortisone has a
relative abundance of approximately 3%, 4% and 35%
compared with cinchocaine in DESI, DAPCI without solvent
and DAPCI with solvent modes, respectively. This demon-
strates the more effective detection of all the active ingredients
in this formulation when using DAPCI with solvent.
Figure 6(A) shows the positive ion mass spectra, over the
regionm/z 340–365, for the same ointment when using DART
and DAPCI with solvent. DART shows results similar to theTable 4. DAPCI-MS/MS accurate mass of m/z 342 [M–H]
of cinchocaine
Measured mass Formulae Error (mTh)
200.1078 C13H14NO 0.3
144.0468 C9H6NO 1.9
Table 5. DAPCI-MS/MS accurate mass of m/z 344 [MþH]þ
of cinchocaine
Measured mass Formulae Error (mTh)
271.1451 C16H19N2O2 0.4
215.0821 C12H11N2O2 0.0
Copyright # 2006 John Wiley & Sons, Ltd.DESI and DAPCI without solvent experiments. The active
ingredient cinchocaine produces the base peak and the peak
due to the hydrocortisone has a relative abundance of
approximately 10% compared with cinchocaine.
Comparison of positive and negative
DAPCI-MS/MS
Metoclopramide is a medicine that increases the movements
or contractions of the stomach and intestines and it is used to
treat the symptoms of a stomach problem called diabetic
gastroparesis. A metoclopramide tablet which contained
10mg of the active ingredient was investigated by DAPCI in
positive and negative ion modes. The negative ion mass
spectrum of metoclopramide is shown in Fig. 7(A). The
deprotonated molecule for the active ingredient wasFigure 5. Top: positive ion DESI-MS spectrum of Proctose-
dyl ointment. The m/z range over m/z 363 (protonated mol-
ecule, [MþH]þ of hydrocortisone) has been expanded
showing a low abundance ion at m/z 363 which has been
magnified (16). Middle: positive ion DAPCI-MS spectrum of
Proctosedyl ointment obtained without solvent. Them/z range
over m/z 363 has been expanded showing a low abundance
ion at m/z 363 which has been magnified (16). Bottom:
positive ion DAPCI-MS spectrum of Proctosedyl ointment
obtained with solvent.
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Figure 6. (A) Positive ion DART-MS spectrum of Proctosedyl
ointment. (B) Positive ion DAPCI-MS spectrum of Proctosedyl
ointment obtained with solvent.
Rapid analysis of pharmaceuticals by DART, DESI and DAPCI 1453observed in the spectrum atm/z 298 and 300. These two peaks
have relative signal intensities of 3:1, consistent with the
presence of one chlorine atom in the molecule. The positive
ion mass spectrum is shown in Fig. 7(B). The protonatedFigure 7. (A) Negative ion DAPCI-MS spe
ion DAPCI-MS spectrum of metoclopramid
mass MS/MS spectrum of m/z 298, the de
clopramide. (D) Positive ion DAPCI accurate
protonated molecule [MþH]þ of metoclopra
trum of metoclopramide. (F) Proposed ne
[M–H] of metoclopramide. (G) Proposed
[MþH]þ of metoclopramide.
Copyright # 2006 John Wiley & Sons, Ltd.molecule for the active ingredient was observed as the base
peak in the spectrum at m/z 300. The positive ion mass
spectrum obtained using DART for metoclopramide is
shown in Fig. 7(E). Once again, the protonated molecule
for the active ingredient at m/z 300 was the base peak.
A comparison of the product ion mass spectra of
protonated and deprotonated metoclopramide is shown in
Figs. 7(C) and 7(D). Figure 7(C) shows the accuratemassMS/
MS spectrum obtained for deprotonated metoclopramide.
The elemental composition assignments for the product ions
are given in Table 6. The deprotonated molecule appears to
fragment by the unusual loss of a methyl radical forming an
odd-electron radical anion of m/z 283. This ion further
fragments to m/z 211 by loss of 72Da, the diethylamine
moiety. Accurate mass measurement confirms this to be a
loss of C4H10N. A proposed fragmentation scheme is shown
in Fig. 7(F).
Figure 7(D) shows the accurate mass MS/MS spectrum
obtained for protonated metoclopramide. The spectrum
shows ions at m/z 227 and 184, in agreement with results
obtained previously.15 The elemental composition assign-
ments for the product ions are given in Table 7. The base peak
in theMS/MS spectrum atm/z 227 shows that the protonated
molecule primarily fragments by the loss of C4H11N,
diethylamine. This ion further fragments to m/z 184 by
loss of 43Da. Accuratemassmeasurement confirms this to be
a loss of C2H5N. A proposed fragmentation scheme is shown
in Fig. 7(G).
Analysis of a naturally occurring plant alkaloid
DAPCI, DESI and DART analysis of tobacco was performed
by removing the tobacco from a cigarette and holding thectrum of metoclopramide. (B) Positive
e. (C) Negative ion DAPCI accurate
protonated molecule [M–H] of meto-
mass MS/MS spectrum ofm/z 300, the
mide. (E) Positive ion DART-MS spec-
gative ion fragmentation pathway of
positive ion fragmentation pathway of
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Table 6. DAPCI-MS/MS accurate mass ofm/z 298 [M–H] of
metoclopramide
Measured mass Formulae Error (mTh)
283.1078 C13H18ClN3O2 0.9
211.0258 C9H8ClN2O2 1.6
197.0106 C8H6ClN2O2 1.2
156.0220 C7H7ClNO 0.3
Table 7. DAPCI-MS/MS accurate mass of m/z 300 [MþH]þ
of metoclopramide
Measured mass Formulae Error (mTh)
227.0592 C10H12ClN2O2 0.4
184.0159 C8H7ClNO2 0.7
Figure 8. (A) Positive ion DAPCI-MS spectru
spectrum of tobacco. (C) Positive ion DART-M
DAPCI accurate mass MS/MS spectrum ofm/z 1
active ingredient nicotine found in tobacco. (E)
way of [MþH]þ of nicotine.
Copyright # 2006 John Wiley & Sons, Ltd.
1454 J. P. Williams et al.contents with tweezers by the method described in the
Experimental section. Nicotine is an alkaloid and is known to
be found naturally in the tobacco plant. The DAPCI, DESI
and DART mass spectra obtained in positive ion mode are
shown in Figs. 8(A)–8(C). A low cone voltage produced a
single ion at m/z 163, corresponding to protonated nicotine,
using DAPCI and DESI. Figure 8(C) shows the spectrum
obtained using the DART source at a high cone voltage. A
high cone voltage produced in-source fragmentation and the
DART spectrum is very similar to the DAPCI-MS/MS
spectrum of m/z 163 shown in Fig. 8(D). The elemental
composition assignments for the product ions obtained for
nicotine are given in Table 8. These show that the protonated
molecule fragments by the loss of 31Da to form an ion at
m/z 132. Accurate mass measurement confirms this loss to be
CH3NH2 from the methyl-substituted pyrrolidine ring. The
base peak in the MS/MS spectrum is m/z 130 formed by lossm of tobacco. (B) Positive ion DESI-MS
S spectrum of tobacco. (D) Positive ion
63, the protonated molecule [MþH]þ of the
Proposed positive ion fragmentation path-
Rapid Commun. Mass Spectrom. 2006; 20: 1447–1456
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Table 8. DAPCI-MS/MS accurate mass of m/z 163 [MþH]þ
of nicotine
Measured mass Formulae Error (mTh)
132.0820 C9H10N 0.7
130.0674 C9H8N 1.7
117.0596 C8H7N 1.8
106.0660 C7H8N 0.4
84.0828 C5H10N 1.5
80.0524 C5H6N 2.4
Rapid analysis of pharmaceuticals by DART, DESI and DAPCI 1455of H2 fromm/z 132. Other ions atm/z 117 and 106 are possibly
formed by the loss of a methyl radical and a C2H2 molecule,
respectively, from m/z 132. The methyl radical loss has been
observed previously.16 Other easily recognised product ions
include the ion of m/z 84 due to the methyl-substituted
pyrrolidine ring moiety obtained from cleavage of the bond
between the two rings and the ion of m/z 80 due to the
pyridine ring moiety of the molecule, obtained in the same
way. A proposed fragmentation scheme is shown in Fig. 8(E),
and is similar to the scheme previously proposed.16 Accurate
mass MS/MS confirms that the previous proposals are
correct.
Identification of ibuprofen metabolites from
human urine
The development of a rapid screen for the detection of drug
or drug metabolites in urine is simplified by the use of these
newly developed ionisation techniques. The study of drug
metabolites in urine can be challenging due to the low levels
of metabolites and high levels of endogenous materials such
as salts. Ibuprofen is a non-steroidal anti-inflammatory drug
and the known bio-transformations of ibuprofen include
hydroxylation, carboxylation and glucuronidation.17 A
control sample of human urine was obtained 60min after
administration of two ibuprofen tablets which each con-Figure 9. (A) Negative ion DAPCI-MS spec
dose of 400 mg of ibuprofen tablets. (B)
spectrum of a urine sample, 75 min after
tablets. The mass spectrum has been exp
(C) Negative ion DAPCI-MS/MS spectrum o
Copyright # 2006 John Wiley & Sons, Ltd.tained 200mg of the active ingredient. We used DAPCI, with
a mixture of methanol/water flowing into the heated probe,
for the detection of ibuprofen metabolites in human urine.
A urine sample was absorbed onto filter paper
(1 cm 8 cm) by placing the paper into the urine sample.
Metabolites in the urine were then identified by holding the
filter paper with tweezers as described in the Experimental
section. Figure 9(A) shows the negative ion mass spectrum
obtained without any pre-treatment of the urine sample. The
spectrum contains ions attributable to the presence of
endogenous components, of which many can be ascribed
to components in the urine and some to background species.
Ions detected other than the known bio-transformations of
ibuprofen have been tentatively assigned to deprotonated
pyruvic acid at m/z 87, lactic acid at m/z 89, methylmalonic
acid at m/z 117, xanthine at m/z 151, and hippuric acid at
m/z 178.
Figure 9(B) shows the accurate mass spectrum obtained
using the deprotonated molecule [M–H] at m/z 205.1229
from the parent drug ibuprofen, as the internal lock mass.
Ions corresponding to the deprotonated molecules of two
low-level metabolites were detected, the hydroxyl-ibuprofen
atm/z 221 and carboxy-ibuprofen atm/z 235. No glucuronide
metabolites were detected. The specificity of the technique
coupled with accurate mass measurement has allowed the
determination of an elemental composition for m/z 221. The
probable elemental composition for the accurate mass of
221.1163 is C13H17O3, consistent with the formula for a
hydroxylated ibuprofen metabolite. The mass error calcu-
lated is1.5mTh from the theoretical monoisotopic mass for
hydroxyl-ibuprofen metabolite. The elemental composition
for the accurate mass of 235.0983 is C13H15O4, consistent with
the formula for a carboxylated ibuprofen metabolite. The
mass error calculated is 1.2mTh from the theoretical
monoisotopic mass for the carboxy-ibuprofen metabolite.
Figure 9(C) shows the MS/MS spectrum obtained for thetrum of urine sample, 75 min after oral
Negative ion DAPCI accurate mass
an oral dose of 400 mg of ibuprofen
anded over the m/z range 195–245.
f m/z 221 showing loss of CO2.
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1456 J. P. Williams et al.deprotonated hydroxy-ibuprofen metabolite at m/z 221. This
primarily fragments with the formation of a single product
ion at m/z 177 through the loss of CO2.CONCLUSIONS
The use of DART, DESI and DAPCI (solvent and solventless)
techniques has been demonstrated for a wide range of
molecules of pharmaceutical interest. In all cases the sample
to be studied has been desorbed from a solid substrate. The
well-demonstrated ability of the DART technique to rapidly
characterise gaseous samples was not utilised. Significant
differences between these approaches were observed. For
compounds of moderate to low polarity, DAPCI (solvent and
solventless) produced more effective ionisation. DAPCI with
solvent was observed to be more effective in the ionisation of
these compounds than DART, DESI or solventless DAPCI.
The previously described approach of ASAP12 was found to
be very similar to solventless DAPCI.
DESI and DAPCI techniques have provided a highly
robust means of interrogating the active ingredients of a
variety of pharmaceutical formulations. Sampling the
formulation is rapid and ionisation occurs almost instantly.
The orientation of the surface in front of the stream of excited
gas seems to be more critical with the DART source. The
current design of the DART source, although very effective
for the analysis of gaseous samples, is less effective for
the analysis of adsorbed molecules. This is due to the
inability of visualise the gas stream and the relatively wide
sampling geometry.
The surface to be analysed via DESI can be held in the
solvent stream at an angle of 458 and at a distance of 5–20mm
prior to the sampling cone orifice or it can be held at an angle
directly in front of the probe tip some distance from the
sampling cone on the QToF 1 instrument. Since the spray
emanating from the probe tip can be seen in DESI mode, the
tip can be positioned exactly to spray the surface to be
interrogated, which can be of the order of cm2 to sub-mm2.
The use of aQ-ToF instrument, with elevated resolution and
full-scan sensitivity, has improved the selectivity and
specificity of the DAPCI technique originally shown by
Cooks and co-workers5 by allowing the generation of accurate
massMS/MS information towithin 2mThusing a single point
internal lock mass to correct mass scale drift. The high
information content has allowed probable elemental compo-
sitions and fragmentation pathways to be determined.
The development of these new ionisation techniques offers
very significant advantages for a number of importantCopyright # 2006 John Wiley & Sons, Ltd.scientific areas. The ability to rapidly analyse complex
mixtures with little, or no, sample preparation is very
important. The techniques DART, DESI and DAPCI (solvent
and solventless) have complex, potentially inter-related
mechanisms but have been shown to provide complemen-
tary information on a range of compounds of pharmaceutical
interest. The direct analysis of urine and molecules adsorbed
on skin is of particular interest. This work has focused on
samples desorbed from solid substrates although the study
of gaseous samples is also possible, particularly with the
DART technique. The techniques produce little fragmenta-
tion and so the addition of accurate mass MS and MS/MS
greatly increases the selectivity of the approach.
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